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CHAPTER 1 
 
Tissue engineering and Biomaterials 
 
1.1 Introduction 
The dream is as old as humankind. Injury, disease, and congenital malformation have 
always been part of the human experience. If only damaged bodies could be restored, 
life could go on for loved ones as though tragedy had not intervened. In recorded 
history, this possibility first was manifested through myth and magic, as in the Greek 
legend of Prometheus and eternal liver regeneration [1]. With the development of 
medicine , man started to interfere with the process that occur within the human body as 
well. The first surgeries took place in ancient Egypt over 4000 years ago, and involved 
the use of non-viable or ‘dead’ materials. For example amputated were replaced with 
wooden toes and linen was used for suturing [2]. Two thousand years later, dental 
implants made of gold  or wrought iron were used by the Romans, Chinese and Aztecs 
[3]. Nowadays tissue or organ transplantation is a standard therapy to treat these 
patients, but this is severely limited by donor shortage. Other available therapies 
including surgical reconstruction, drug therapy, synthetic prostheses, and medical 
devices are not limited by supply, but they do have other problems. For example, 
synthetic prostheses and medical devices are not able to replace all the functions of a 
damaged or lost organ or tissue [4]. The efforts to address these problems and 
limitations have elicited the development of new biomaterials and alternative therapies. 
Over the years, various definitions of the term biomaterials have been proposed. For 
example, a biomaterial can be simply defined as a synthetic material used to replace 
part of a living system or to function in intimate contact with living tissue. The Clemson 
University Advisory Board for Biomaterials has formally defined a biomaterial to be “a 
systemically and pharmacologically inert substance designed for implantation within or 
incorporation with living systems” [5]. Black defined biomaterials as “a nonviable 
material used in a medical device, intended to interact with biological systems” [6] 
Other definitions have included “materials of synthetic as well as of natural origin in 
contact with tissue, blood, and biological fluids, and intended for use for prosthetic, 
diagnostic, therapeutic, and storage applications without adversely affecting the living 
organism and its components” and “any substance (other than drugs) or combination of 
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substances, synthetic or natural in origin, which can be used for any period of time, as a 
whole or as a part of a system which treats, augments, or replaces any tissue, organ, or 
function of the body” [7]. According to these definitions one must possess knowledge in 
a number of different disciplines or collaborate with individuals from a wide variety of 
different specialties in order to properly develop and use biomaterials in medicine. 
Likewise, advances in materials science, chemical engineering, and bioengineering 
allow the rational application of engineering principles to living systems. 
Tissue engineering has emerged as a promising alternative approach to treat the loss or 
malfunction of a tissue or organ without the limitations of current therapies 
[8][9][10][11]. As a field, tissue engineering has been defined only since the mid-1980s 
and it combines the principles of biology, engineering, and medicine to create biological 
substitutes for lost or defective native tissues [12].  
 
Fig. 1.1: multidisciplinary nature of the tissue engineering field. 
 
The principle of TE is to culture cells into a matrix and incorporate it into the body. The 
matrices are made of natural materials such as collagen or from synthetic polymers. 
The first definition of tissue engineering was provided by Skalak and Fox (1988) who 
stated it to be “the application of principles and methods of engineering and life 
sciences toward the fundamental understanding of structure-function relationships in 
normal and phatological mammalian tissues and the development of biological 
substitutes to restore, maintain or improve tissue function”[13].  
Tissue engineering, through the imitation of nature, has the potential to confront the 
transplantation crisis caused by the shortage of donor tissues and organs and also to 
address other important, but yet unmet, patient needs [1]. To engineer living tissues in 
vitro, cultured cells are coaxed to grow on bioactive degradable scaffolds that provide 
the physical and chemical cues to guide their differentiation and assembly into three-
dimensional (3D) tissues [14].  
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1.2 Porous scaffold for tissue engineering 
The scaffold or three-dimensional (3-D) construct provides the necessary support for 
cells to proliferate and maintain their differentiated function, and its architecture defines 
the ultimate shape of the new bone and cartilage [15]. The strategy for Tissue 
Engineering is divided in six steps (Figure 1). In the first step, cells need to be extracted 
from the patient. Then, it is necessary to isolate the desired cell type from the crude cell 
extract. The isolation is essential because this is a selection of cells we want to use and 
grow for our TE application. In many cases, the population of the desired cells is very 
low, thus it is essential to growth and expand the population of these cells in vitro. This 
step is very important when working with stem cells because the stem cells need to be 
maintained in their pluripotent state while their population is increased. Once we have 
sufficient number of cells, they are implanted in a matrix, called scaffold. The scaffold 
offers a suitable environment to permit cells to stick, growth, and develop in the right 
direction. This proliferation is now controlled and catalyzed by the scaffold design and 
coating. Finally, the scaffold with its inner and outer cells is ready to be implanted into 
the patient by the surgeon[16]. 
 
Fig. 1.2: Principle of scaffold-based tissue engineering. 
 
Architectural features , namely pore size and shape, pore wall morphology, porosity, 
surface area and pore interconnectivity, are probably the most critical parameters as 
those have been shown to directly impact cell seeding, cell migration tissue 
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differentiation, transport of oxygen, nutrients and wastes and new tissue formation in 
three dimensions[17][18]. Approaches in scaffold design must be able to create 
hierarchical porous structures to attain desired mechanical function and mass transport 
(that is, permeability and diffusion) properties, and to produce these structures within 
arbitrary and complex three dimensional (3D) anatomical shapes. Hierarchical refers to 
the fact that features at scales from the nanometre to millimetre level will determine 
how well the scaffold meets conflicting mechanical function and mass-transport need. 
The scaffolds also provide temporary mechanical support to the regenerating tissue. 
They must degrade into biocompatible products, ideally on a time scale comparable to 
that of new tissue development. Such scaffolds are typically fabricated with 
biocompatible polymers, proteins, peptides, and inorganic materials. Today, four types 
of material have been experimentally and clinically studied as scaffold material: (A) 
synthetic organic materials; (B) synthetic inorganic materials: hydroxyapatite, 
tricalciumphosphate; (C) organic materials of natural origin: collagen, hyaluronic acid; 
(D) inorganic material of natural origin: coralline hydroxyapatite [19]; the intrinsic 
material properties, such as the mechanical or thermal behaviour of a polymer play a 
role in the utilization of tissue engineering and also in the embodiment and the 
morphology of the shaped scaffold body [20]. The scaffold should be fabricated from a 
highly biocompatible material, which does not have the potential to elicit an 
immunological, or clinically detectable primary or secondary foreign body reaction. 
Furthermore, a polymer scaffold material has to be chosen that will degrade and resorb 
at a controlled rate [21]. Aside from the properties of the raw material, the major factor 
determining the final scaffold characteristics is the fabrication technique utilized to 
produce the scaffold [22].  
In addition to acting as a bare physical support, scaffolds can be engineered to provide 
biological functions and actively induce tissue regeneration. Biocompatibility, or tissue 
tolerance is not enough. A general theory of biomaterials was expressed by henche and 
Ethridge in 1982 as[23]: 
• An ideal implant material perform as if it were equivalent to the host tissue 
• The tissue at the interface should be equivalent to the normal host tissue 
• The response of the material to physical stimuli should be like that of the tissue 
replaced 
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A stable interfacial bond between tissue and implants must be achieved in order to 
obtain an equivalent physical response, and controlled physical stimuli is necessary for 
a stable interface to be produced.  
 The surface of a 3D scaffold, for example, can be functionalized to promote cell 
adhesion through specific cell–matrix interactions. In fact, the formation of complex 
tissues from single cells and tissue maintenance needs large amounts of information 
which must be transported from cell to cell and from cells to ECM. 
 
Fig. 1.3: Tissue engineering approaches are classified into three categories: (I) cells alone, (II) cells 
with scaffolds, and (III) scaffolds alone. 
 
Since regeneration is an instance of induced in vivo synthesis, the activity of scaffolds 
has been described in terms of the quality of products induced to regenerate in the 
presence of these scaffolds. Their unique biological activity appears to lie primarily in 
their ability to regulate cell function through specific cell-matrix interactions involving 
integrins, mostly those fibroblasts and myofibroblast, and ligand on the matrix surface 
[24].  Activity is also conferred by chemical composition, which determines the identity 
of ligands; the specific surface of the porous network; the orientation of pore channels, 
which determines the spatial configuration of ligands; and the scaffold degradation rate 
which depends on the chemical composition as well as the cross-link density of the 
macromolecular network and determines the duration of the active surface.  
In bone tissue engineering, the understanding of boneforming behavior of cells must be 
combined with progress in material science, to achieve guided bone regeneration. The 
scientific community is taking up this challenge through the employment of insoluble 
signals integrated with the degradable polymer matrix. These act as reinforcement 
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agents as well as osteoconductive signals, offering a valid compromise between the 
mechanical response and bioactivity of the scaffold. Many papers propose the use of 
calcium phosphates such as hydroxyapatite (HA) to stimulate a biochemical response 
from living tissues, to obtain a strong bond between the scaffold and the adjacent tissue 
with positive results[25]. 
 
1.3 Aim and structure of the thesis 
The aims of this thesis are: 
• To develop porous composite scaffold based on polyester and hydroxyapatite for 
bone regeneration using different techniques 
• To charachterise these scaffold from a morphologic, mechanical and biological 
point of view.  
• To design, prepare and characterise porous PDLLA scaffold, obtained by 
stereolithography. 
• To develop new photo-crosslinkable composite resin suitable for 
stereolithography application. 
 
In Chapter 2, a review on scaffold fabrication techniques is described. Their principles 
of operation are briefly explained underlining main advantages and shortcoming. Most 
part of the chapter is dedicated to the solid freeform fabrication technique with aprticalu 
attention to stereolithography and its biomedical application.  
In Chapter 3, we describe the preparation of PCL and composite PCL/HAP scaffolds 
obtained with the phase inversion/salt leaching technique. The mechanical and 
morphological  properties of the scaffold are determined analyzing also their 
osteoconductive properties. 
In Chapter 4, two different technique to produce reinforced bioactive scaffold is 
compared. PCL composite scaffolds are obtained by incorporating poly(L-lactide) 
(PLLA) continuous fibers within a PCL matrix through the synergic combination of 
phase inversion/salt leaching technique and the filament winding technology. Then the 
structures are compared from a mechanical and morphological point of view with 
traditional PCL scaffold reinforced with calcium phosphate particles. Finally an in vivo 
test have been performed by Orthopaedic institute Rizzoli in Boulogne.  
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Chapter 5 reports the use of methacrylate-functionalised PDLLA oligomers with a non-
reactive diluent for stereolithography application. Different porous architecture are 
prepared and compared from a morphological point of view. Double gyroid network 
architecture are chosen for the in vitro test and are seeded with hMSCs for 21 days.  
In Chapter 6 we describe the preparation of a composite PDLLA/ nano HAP resin for 
application in stereolithography. Double gyroid structure are prepared and characterized 
to evaluate the effect of nano-HAP on mechanical and biological properties. 
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CHAPTER 2 
A review of scaffolds fabrication techniques 
 
2.1 Introduction 
Since the mid-1980s, researchers have developed many novel techniques to shape 
polymers into complex architectures that exhibit the desired properties for specific 
tissue-engineering applications. These fabrication techniques result in reproducible 
scaffolds for the regeneration of specific tissues. The scaffold should provide to a three- 
dimensional (3D) template that supports temporary loads driving the growth of the 
tissue to form its final shape[1]. In order to perform a complex biological and sensititve 
system such as the human body tissue, the requirements of scaffold materials for tissue 
engineering are manifold and extremely challenging[2]. First, the main requirement for 
a scaffold, particularly in bone tissue engineering is a controllable interconnected 
porosity to direct the cells to grow into the desires physical vascularisation of the 
ingrown tissue[3][4]. The scaffold morphology  is determined by the fabrication method 
and by varying the component dimensions, scaffolds can be formed with porosity and 
strengths that are significantly different to their original morphology [5]. These key 
scaffold characteristics can be tailored to the application by careful selection of the 
polymers, additional scaffold components, and the fabrication technique [6]. A number 
of fabrication technologies have been applied to process biodegradable and 
bioresorbable materials into 3D polymeric scaffolds of high porosity and surface area. 
From a scaffold design and function viewpoint each processing methodology shows 
several advantages and shortcomings. In this chapter, different methods for scaffold 
design and preparation are summarized with specific emphasis on stereolithography 
(RP) technique.  An important part of this thesis will be focused on the architecture of 
the pore network of tissue engineering scaffolds, on the preparation of scaffolds with 
different architectures and their functionality in tissue engineering. 
 
2.2 Conventional techniques 
The conventional techniques of scaffold fabrication: solvent leaching, gas foaming, 
vacuum drying, and thermally induced phase separation (TIPS) in combination with salt 
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leaching produce foam-like structures which are generally classified in the engineering 
literature as cellular solids [4] Porosity and pore size can be controlled by varying the 
particle/polymer ratio and particle size.  
 
Fig. 2.1: Conventional technique commonly used in tissue engineering: A) textile, B) salt leaching, 
C) Gas foaming. 
 
2.2.1 Salt Leaching 
Particulate leaching method involves the casting of a polymer/porogen composite 
followed by the dissolution of the porogen. Polymer porous membranes of 
controlled porosity, surface/volume ratio, and crystallinity were prepared with 
porogen weight fraction, and the median pore diameter increased as the porogen 
particle size increased [7].  
 
Fig. 2.2: schematic description of particulate leaching. 
 
It is a simple and user friendly method, suitable with a range of biomaterials and no 
special equipment is needed. 
2.2.2 Gas foaming 
It is a technique to fabricate macro-porous sponges from synthetic biodegradable 
polymer using high pressure carbon dioxide processing at room [7]. Solid discs of 
polymer were saturated with CO2 by exposure to high pressure CO2gas for hours at 
room temperature. The solubility of the gas in the polymer was then rapidly 
decreased by reducing the CO2 gas pressure to atmospheric levels. This created a 
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thermodynamics instability for the CO2 dissolved in the matrix. Polymer sponges 
with large pores (approximately 100?m) and porosities of up to 93% could be 
fabricated with this technique [9].   
 
Fig. 2.3: schematic description of gas foaming. 
 
Salerno et all prepared open-pore biodegradable foams with controlled porosity 
architectures using gas foaming micro-particulate of poly (ε-caprolactone ) as is 
possible to see in figure 5 [10]. 
2.2.3 Thermal induced phase separation 
Thermal-induced phase separation (TIPS) has been show to be an excellent 
technique to make micro-porous polymeric membranes. After a polymer is 
dissolved in a solvent at high temperature , phase separation by spinodal 
decomposition is induced by cooling or quenching the solution [11].   
 
Fig. 2.4: schematic description of spinodal decomposition [7][12]. 
 
The TIPS process is classified mainly into two types such as solid-liquid TIPS, 
where the polymer crystallizes out of the solution, and liquid-liquid TIPS, where the 
solution separates into a polymer rich continuous phase and a droplet phase. Phase 
separation continues until the polymer-rich phase becomes immobilized by gelation, 
glass transition, or crystallization. Once this occurs, the structures is effectively 
frozen into a place and the solvent can be removed from the film [13]. Fully 
interconnected pores and large pore interconnections can be fabricated if spinodal 
decomposition is totally achieved. However, there are numerous drawbacks to 
applying those techniques for tissue engineering applications. These conventional 
technique are incapable of precisely and repeatedly controlling the microstructures 
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of the scaffold in term of pore size, geometry, interconnectivity and spatial 
distribution of pores. The pores are not fully inter-connected due to the formation of 
skin layers during solvent evaporation. The pore size varies, as it is difficult to 
ensure that the porogens are well-dispersed and not agglomerated to form bigger 
particles. Pore walls thickness, length  and edges changes as a function of the 
solvent evaporation rate. The scaffolds cannot be made with thick sections as deeply 
embedded porogens become too distant from the surface and residual porogens may 
be left in the final structure [14]. Moreover organic solvents are used and causes 
problem of biocompatibility.  
 
2.3 Rapid prototyping 
In many scaffold manufacturing techniques, the control of the internal architecture and 
interconnectivity is limited Conventional scaffold processing techniques are, in fact, 
incapable of precisely controlling pore size, pore geometry, spatial distribution of pores 
and construction of internal channels within the scaffold[15]. To overcome the 
drawbacks of the conventional techniques, rapid Prototyping (RP) methods are 
attracting the interest of the TE community. The RP techniques allow the fabrication of 
very complex 3d structure in a layer-wise fashion in a reproducible way [16]. Rapid 
Prototyping (RP), also termed “solid freeform fabrication (SFF),” is a technology based 
on the advanced development of computer and manufacturing. All prototypes made 
with the current evolving RP process have several features in common [17][18]. A solid 
surface CAD model is electronically sectioned into layers of predetermined thickness. 
These sections define the shape of the part collectively. Information about each section 
is then electronically transmitted to the RP machine layer by layer. Subsequent layers 
are sequentially processed until the part is complete. The RP process basically uses the 
following steps to make prototypes: 
• create a CAD model of the design. 
• convert the CAD model to STL file format. 
• Slice the STL file into 2D cross-sectional layers. 
• Grow the prototype 
• Postprocessing 
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Fig. 2.5: The Solid Models as a: (a) Solid Model,  (b) an STL file, and (c) in Sliced Layers 
 
RP has the advantages of being able to build structures with customized shapes and 
better control over localized pore morphologies, porosities and material composition to 
suit the requirements of multiple cell types arranged in hierarchical structures. 
Over the past two decades,  more than 20 RP systems were developed and 
commercialised [19] with a focus on the rapid manufacturing of prototypes for non-
biomedical applications. Very recently, biomaterial scientists used these technologies to 
fabricate scaffolds for tissue engineering. SFF techniques offer unique ways to precisely 
control matrix architecture (size, shape, interconnectivity, branching, geometry and 
orientation) yielding biomimetic structures varying in design and material composition, 
thereby enhancing control over mechanical properties, biological effects and 
degradation kinetics of the scaffolds. RP has been used in the medical field primarily as 
a means of guiding surgical procedures using tactile models derived from patient 
computerized tomography (CT) data [20].  
 
Fig. 2.6: Graphical illustration of a concept to build a customized 3D scaffold via robot supported 
micro assembly[4]. 
 
Direct fabrication of custom implants is promising in offering simpler and more rapid 
surgical implementations. The potential to intimately control the microstructure of 
porous channels and the overall macroscopic shape of the implants makes RP an ideal 
process for fabricating implant and tissue engineering scaffold as well. For the 
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fabrication of tissue engineering scaffold, SFF techniques have several advantages over 
conventional techniques: 
• Excellent control over (pore network) design and properties; 
• Excellent reproducibility 
• Improved mechanical properties 
• Higher pore interconnectivities 
• Better suited for modelling. 
The various RP&M technologies for tissue engineering, described in the following 
sections, include stereolithography processes, laser sintering, extrusion and 3D 
printing. 
2.3.1 3D printing (3DP) 
Basically the 3DP is a layered fabrication process, in which the sliced 2D profile of 
a computer model is printed on a fresh layer of powder via deposition of a suitable 
binder. Successive 2D profiles are then printed on a freshly laid layer of powder 
until the whole model is completed. The specimen is completed upon removal of the 
unbound powder and suitable post-processing [21]. 
 
Fig. 2.7: Schematic overview of 3D printing method [22]. 
 
Recently the capability of creating complex 3D structures attracted tissue engineers 
to apply the technology to design and fabricate scaffolds [23]. With this method it is 
possible to obtain porosity of 45-60% with pore size in the range of 45 - 1600?m. 
The layer-by-layer process allowed fabrication of complex architectures with 
excellent resolution. Moreover, significant times are required to manufacture 
scaffold with suitable techniques [24].  
CHAPTER 2 A review of scaffolds fabrication techniques 21 
 
 
2.3.2 Selective laser sintering (SLS) 
SLS uses a fine powder of material which is heated with CO2 laser of power in the 
range of 25-50 W such that the surface tension of the grain are overcome and they 
fuse together. Before the powder  is sintered, the entire bed is heated to just below 
the melting point of the material in order to minimize thermal distortion and 
facilitate fusion to the previous layer.  
 
Fig. 2.8: schematic view of the selective laser sintering techniques [22]. 
 
Each layer is drawn in the powder bed using the laser to sinter the material. Then the 
bed is lowered and a powder-feed chamber raised. A new layer of powder is 
deposited and spread by a counter rotating roller. The sintered material forms the 
desired structure while the undesired powder remains in place to support the 
structure and may be cleaned away and recycled once the process is completed.  
Only porosity up to 40% could be obtained, with pore size in the range of 30-
2500?m. Once again, an accurate control over pore size and interconnectivity can be 
achieved and the layer-by-layer process allowed fabrication of complex and 
anatomically-shaped structures. 
2.3.3 Fused Deposition Modelling 
Fused deposition modeling (FDM) (Crump 1992) is a process whereby a molten 
material is extruded through a nozzle and deposited as a layer on a surface. At the 
completion of the layer deposition, the sample stage is lowered and a new layer is 
deposited. In this fashion, the technique fabricates a 3D structure. A benefit of this 
method is the absence of organic solvents in the fabrication process. The computer-
aided process is  controlled by the use of CAD data in the design of the scaffold. 
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The technique has been used to prepare porous scaffolds from polymers such as 
PCL [25], PEG-PCL-PLA [26], and PCL/HA composite [27].  
 
Fig. 2.9: Schematic description of fused deposition modelling [22]. 
 
Large porosity up to 80% can be achieved, with pore size in the range of 100-2000 
?m. The exact control of pore size and interconnectivity can also be obtained 
[28][29]. 
 
2.4 Stereolithography  
Stereolithography is an additive fabrication process using a liquid UV-curable 
photopolymer and a UV laser to build structures a layer at a time. Stereolithographic 
processes produce 3D solid objects in a multi-layer procedure through the selective 
photo-initiated cure reaction of a polymer (Bártolo and Mitchell, 2003). These processes 
usually employ two distinct methods of irradiation. The first method is the mask-based 
method in which an image is transferred to a liquid polymer by irradiating through a 
patterned mask. The irradiated part of the liquid polymer is then solidified. These 
systems generally require the generation of a lot of masks with precise mask 
alignments. In the second method, a direct writing process using a focused UV beam 
produces polymer structures[22].  
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Fig. 2.10: Conventional Stereolithography system[22]. 
 
Generally, SL is considered to provide the greatest accuracy and best surface finish of 
any RP technology. The model material is robust, slightly brittle, and relatively light, 
although it is hydroscopic and may physically warp over time (a few months) if exposed 
to high humidity [30]. Although fine structures can be produced by the laser  SL 
technique, the process is usually slow because of the nature of point-by-point laser 
scanning. This prevents the incorporation of cells within the scaffold walls during the 
fabrication process and could also lead to denaturation and inactivation of biological 
molecules during the prolonged fabrication period [31]. One solution for this problem is 
the use of a Liquid Crystal Display (LCD) or a digital processing projection system as a 
flexible mask. Microstereolithography is a relatively recent development, similar to 
conventional stereolithography. There are three methods of microstereolithography and 
they have differences in the laminate on and solidification processes. The first is free-
surface method that is the subject of this study [32]. In this method, UV curable resin is 
exposed to UV laser beam above the free-surface of the resin and the resin at the surface 
is solidified. The second is fixed-surface method. In this method, UV curable resin is 
exposed to UV beam toward flatly transparent window that is immersed in the resin and 
the resin at the surface formed by this window is solidified [33]. This method has a 
higher resolution than free-surface method. However, the yield of this method is low 
because adhesion between the resin and the window causes destruction of a solidified 
structure. The third is inside-solidification method [34]. Unlike the two methods 
described above, in this method resin is solidified at not the surface, but a point inside 
the UV curable resin.  
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Fig. 2.11: The methods of microstereolithography 
 
This method presents an high resolution of submicron order, and can fabricate movable 
microstructures without the support. However, the size of a structure is restricted to 
several tens of micrometers because this method must use objective lens with high 
numerical aperture [33]. Bertsch and colleagues reported a ?SL process employing a 
liquid crystal display (LCD) as a dynamic mask to photopolymerize an entire layer [35]. 
However, LCD as a dynamic mask has limited optical efficiency [36]. A new 
technology, Digital Micro-mirror Device™ (DMD, Texas Instruments, Dallas, TX), 
offers better performance in terms of optical fill factor (85% with DMD vs. 64% with 
LCD) and light transmission (71% with DMD vs. 21% with LCD)[31]. 
 
Fig. 2.12: Schematic of the Digital Micro-mirror Device Micro-stereolithography (DMD-?SL) set-
up [31]. 
 
The shapes of these constructed layers are determined by slicing the design CAD model 
with a series of closely spaced horizontal planes. By taking the sliced layer patterns in 
the electronic format, the mask patterns are dynamically generated as bitmap images on 
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a computer-programmable array of digital micro-mirrors on the DMD chip. The arrays 
of aluminium micro-mirrors are anchored on top of addressable SRAM CMOS 
circuitries, and two positions are permitted for the mirror to tilt at +10◦ or −10◦ along its 
diagonal [36]. By toggling the voltage applied to the individual micro-mirror, the mirror 
can be switched between stable positions with the light reflecting “on” and “off” 
directions. Large porosity could be obtained with this method (~90%), with pore size in 
the range of 20-1000 ?m. The light illuminated on the DMD chip is shaped according to 
the defined mask pattern, and then, the modulated light is transferred through a 
reduction lens. Hence, an image is formed on curable resin surface with a reduced 
feature size. In each layer, the illuminated area is solidified simultaneously under one 
exposure, while the dark regions remain liquid. After the fabrication of one layer, the 
substrate is immersed into the UV curable resin and the new layer is fabricated on top of 
the existing structure. A complex, geometrically shaped microstructure can be 
fabricated by building all the layers sequentially and stacking them from bottom to top. 
The dynamic mask is the core component of the ?-SL system that determines the shape 
of the fabricated microstructure. As the dynamic mask, the DMD modulates the light by 
collectively controlling the micro-mirror arrays to switch the light on and off on each 
individual pixel. An accurate control over pore size and interconnectivity can be 
achieved. The layer-wise fashioned process allowed fabrication of complex and 
anatomically-shaped structures [37][37].  
 
 
Fig. 2.13: 3D complex microstructures fabricated by ?-SL process[36] 
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.  
However, the machinery required are very expensive and only polymers compatible 
with UV curing can be used. The development of new biodegradable resin would allow 
the preparation of well-defined tissue engineering scaffolds for a wide range of tissues.  
In SLA, control of thickness of the layer that is cured is essential. For a given resin, the 
cure depth is determined by the energy of the light to which the resin is exposed. This 
energy can be controlled by adjusting the power of the light source, and the scanning 
speed (laser system) or the exposure time (projection system). Upon laser exposure, the 
photopolymer obeys the Beer–Lambert law of absorption. Earlier macro-scale 
experiments suggested that the photopolymer has a threshold exposure and curing 
depth, can be expressed in the following working curve as: 
c
pd E
ElnDC =  
where Cd is the curing depth, Dp  is the penetration depth of the resin defined as D = 
(2.3*ε[J]) (ε is the molar  extinction coefficient of the initiator, [J] is the initiator 
concentration), and E and Ec are the laser exposure on the resin surface and critical 
exposure of the resin at the laser wavelength, respectively [38]. A plot of the determined 
cure depth (or cured layer thickness) versus the applied irradiation dose is termed a 
working curve, and is constructed to determine the correct settings for stereolithography 
fabrication. As the applied irradiation dose (E) exceeds the critical energy required to 
reach the gel point (Ec), a solidified layer forms from the resin surface. The value of Ec 
depends, among on the concentration of photo-initiator, and of dissolved oxygen and 
other inhibiting species. To ensure chemical and mechanical bonding between the layers 
during building , the macromers conversion at the interface between layers should be 
slightly higher than the gel point [39]. A high extinction coefficient of the resin 
corresponds to a low light penetration depth (Dp), and will allow most accurate control 
of the polymerisation process and minimal over-cure. The penetration depth can be 
decreased by increasing the photo-initiator concentration, or by including a dye in the 
resin. This non reactive component competes with the photo-initiator in absorbing light.  
As shown in Fig. 14, the experimental measurements of working curves of UV curable 
resins are obtained by measuring the curing depth under various UV exposures. The 
curing depth is linearly proportional to the natural logarithm of UV exposure, which is 
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in good agreement with the numerical mode. Under the same UV exposure, the resin 
with 0.3% UV doping has a smaller curing depth [36]. 
 
Fig. 2.14: Measured curing depth vs. incident UV light exposure at different doping level 
 
2.4.1 Photopolymer used in stereolithography 
In stereolithography, parts are built from a photosensitive polymer fluid that cures 
under the exposure to a laser beam. Photopolymers are solidified (cured) when 
exposed to electromagnetic radiation with a specific wavelength including γ rays, X-
rays, UV, visible light and infrared. Photopolymerizations also offer improved 
temporal control of the initiation process when compared to methods such as redox 
initiation systems, as they are controlled by the presence of light [40].  The 
polymerizations are complete in a minimal amount of time, making them ideal for a 
surgical setting. The rate can be adjusted by altering the polymerization conditions, 
including the choice and concentration of the photoinitiator, the concentration of 
reactive double bonds in the formulation, the wavelength of the light source (UV or 
visible), as well as the light intensity. Perhaps the limited number of resin that are 
commercial available for processing by stereolithography has often been considered 
the main limitation of the technique. The resin should be a liquid that rapidly 
solidifies upon illumination with light. Acrilate-based photopolymers are the most 
widely used resin system developed for stereolithography [41]. Only few resin have 
been described  that allow the preparation of elastomeric object by 
stereolithography. It has been shown [42] that poly(propylene fumarate) (PPF) 
mixed with a photoinitiator can be crosslinked by exposing it to a concentrated flood 
of UV light through a translucent mold. It requires a reactive diluent such as diethyl 
fumarate to obtain an appropriate reaction rate and viscosity of the resin [43]. 
Matsuda et al.  reported use of a custom-built SLA device to 3D-print a structure 
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from ε-caprolactone [44]. This resin formulations include macromers with low glass 
transition temperature  and relatively high molecular weights (1-5 kg/mol), often in 
combination with non-reactive diluents such as N-methylpyrollidone (NMP) or 
water to reduce the viscosity of the resin. To create polymer-ceramic composite 
objects ceramic particles (Hydroxyapatite) are homogeneously suspended in the 
resin and photo-polymerised in the SLA [45][46]. The ceramic powder is used 
because it elicit osteconductive and osteoinductive properties and  decreases the 
penetration depth of the incident light improving the vertical resolution of the 
process. Moreover, the mechanical properties of the manufactured parts are also 
increased [47][48], and become sufficient to allow the manufactured microparts to 
be directly used as microcomponent. Popov et al prepared non-resorbable 
polyacrylate and hydroxyapatite composite parts, and implanted them into the 
femurs of rats for time periods of up to 8 weeks [49]. This show that anatomically 
shaped implants, compatible with cells and surrounding tissues can be manufactured 
using stereolithography.  
 
2.5 Medical application of rapid prototyping 
One area in which rapid prototyping is having a great impact is the medical field. Some 
of the application include surgical planning and the fabrication of prosthetic. The field 
of medicine gratly benefits from the development and improvement of rapid prototyping 
technology. The number of medical applications of rapid prototyping are increasing 
everyday, making the future of RP more and more promising. The creation of medical 
models requires a number of steps: the acquisition of high-quality volumetric (3D) 
image data of the anatomy to be modelled, 3D image processing to extract the region of 
interest from surrounding tissues, mathematical surface modelling of the anatomic 
surfaces, formatting of data for RP (this includes the creation of model support 
structures that support the model during building and are subsequently manually 
removed), model building, and quality assurance of model quality and dimensional 
accuracy. These steps require significant expertise and knowledge in medical imaging, 
3D medical image processing, computer-assisted design, and manufacturing software 
and engineering processes [30]. With the progress in computer-aided design and 
manufacturing technologies, it is now possible to make use of this information in 
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conducting the surgery itself by making use of patient-specific models of parts of the 
body fabricated by stereolithography [50]. Noteworthy, biodegradability is essential in 
the fabrication of medical implants such as tissue engineering scaffolds. A degradable 
photo-polymerisable system can be obtained by chain-crosslinking hydrolysable 
oligomers with reactive end-groups [51][52]. To be able to apply PDLLA macromers in 
stereolithography, the macromer must be in the liquid state. This can be achieved by 
heating or diluting. Reactive diluents such as methyl methacrylate, butane-
dimethacrylate and N-methyl-2-pyrrolidone have been used in regular photo-
polymerisation reactions [53] and in stereolithography [51].  
 
2.6 Design and fabrication of  biomorphic scaffolds by stereolithography 
The scaffolds suitable for tissue engineering, apart from being biocompatible and 
biodegradable, should present highly interconnected pores; have sufficient mechanical 
properties; and, provide a suitable substrate for cell attachment, migration and 
proliferation [54]. However, the majority of existing approaches under-utilize SFF by 
producing CAD based scaffolds with straight edges and sharp turns or those derived 
from Boolean intersections of geometric primitives such as spheres and cylinders. 
Neither of these partitions provides a biomorphic environment suitable for cell 
attachment, migration and proliferation [55]. The biomorphic geometry that best mimics 
this structural configuration would be surfaces that are continuous through space and 
divided into two (pore and non-pore) not-necessarily-equal sub-spaces by a 
nonintersecting two-sided surface. Minimal surfaces are ideal to describe such a space. 
TPMS are minimal surfaces periodic in three independent directions, extending 
infinitely and, in the absence of self-intersections, partitioning the space into two 
labyrinths. Figure 1 shows the TPMS Primitive (P) surface, the Diamond (D) surface 
discovered by Schwarz [6] and the Gyroid (G) surface discovered by Schoen [56].  
 
Fig. 2.15: 3-Dimensional tessellations of Schwarz's Primitive (left), and Diamond (centre) and 
Schoen's Gyroid (right) Triply Periodic Minimal Surfaces. 
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Surfaces whose mean curvature H is everywhere zero are minimal surfaces – any 
sufficiently small patch cut from a minimal surface has the least area of all surface 
patches with the same boundary. The triply periodic minimal surfaces (TPMS) are 
particularly fascinating because they are without self intersections and partitionate the 
space into two labyrinths [56][57]. This viable morphology, when replicated at macro 
(tissue) level may also have profound influence on cell migration and tissue growth and 
may provide an optimal biomorphic tissue analogue [55]. 
 
Conclusion 
Tissue engineering is based on the concept that cells seeded onto 3D bioresorbable 
scaffolds can build native tissues under suitable in vitro and in vivo conditions. Ideally, 
a scaffold material should permit the application of a solid free form fabrication 
technology, so that a porous scaffold with any desired three-dimensional morphology as 
well as shape could be designed and fabricated. Several techniques have been developed 
to process synthetic and natural scaffold materials into porous structures. The 
conventional techniques for scaffold fabrication (textile technologies, solvent casting, 
particulate leaching) are defined as processes that create scaffolds having a continuous, 
uninterrupted pore structure which lacks any long-range channelling microarchitecture. 
Solid freeform fabrication systems provide a solution to this problem by creating 
scaffolds with controlled internal microarchitecture, which should increase the mass 
transport of oxygen and nutrients deep into the scaffold. Several systems have been 
successfully adapted to produce synthetic and natural biodegradable polymer, 
bioceramic and hydrogel scaffolds. in particular stereolithography is a SFF technique 
that is particularly versatile with respect to the freedom of design of the structures that 
are to be built. Moreover the development of new resin has enabled to fabricate 
biodegradable devices with open architectures for biomedical engineering purpose.  
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CHAPTER 3 
Bioactivation of PCL matrices by calcium phosphate 
solid signals. 
 
3.1 Introduction 
Critical step of all tissue engineering techniques is the use of a tridimensional structure 
which, mimicking the extracellular matrix (ECM), serves as scaffold which is able to 
promote and guide actively the tissue regeneration process [1]. In vitro and in vivo 
tissue engineering strategies generally include signalling molecules, which should try to 
reproduce the natural sequence of signals guiding spontaneous tissue repair, cells, in 
case tissue is not able to regenerate by itself, and if necessary a scaffold, which provides 
a mechanical support to the development of neotissue [2]. Bone tissue engineering is a 
promising fields that aims  to fabricating biological alternatives for harvested tissue and 
organ for transplantation without the limitations of current therapies [3]. In contrast to 
traditional surgical methods of bone-defects management, this approach relies on three-
dimensional structures for temporary replacement of damage tissue, mimicking its 
morphology and physiological function [4]. The scaffold or three-dimensional construct 
provides the necessary support for cells to proliferate and maintain their differentiated 
functions, and its architecture defines the ultimate shape of the new bone and cartilage 
[5]. Furthermore the selection of the most appropriate material to produce a scaffold is a 
primary aspect for the construction of a final tissue engineered product [4]. It is possible 
to distinguish four types of biomaterials, according to their natural or synthetic origin, 
and organic or inorganic nature [5]: (A) natural based materials from animal or vegetal 
source (starch[6], alginate) (B) Synthetic organic materials, such as polyester (e.g. 
polyglicolide, polylactide [7], polydioxane [8], polycaprolactone, and polyhanydrides 
[9]), (C) synthetic and (D) natural inorganic materials such as hydroxyapatite (HA)[10], 
calcium phosphate composites [11], glass and coralline HA [11][12]. Several scaffold 
material have been investigated for tissue engineering including hydroxyapatite (HA), 
poly(α-hydroxyesters), and natural polymers such as collagen and chitin [14]. 
Polycaprolactone (PCL) is a semicrystalline linear resorbable polyester widely used for 
biomedical application. It is subjected to biodegradation because of the susceptibility of 
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its aliphatic ester linkage to hydrolysis [15][16]. In vitro and in vivo biocompatibility 
studies have been performed on this polymer, resulting in U.S. Food and Drug 
Administration approval of a number of medical and drug devices [17][18]. On the 
other hand polyester represent some limitation due to the inflammatory response and the 
inhibition of tissue formation [5]. Biocompatibility does not solely imply a lack of 
toxicity or the ability to be chemically compatible with the host tissue. The term has 
been used to describe the ability of a material not to elicit a response from the host 
tissue on implantation: a biocompatible material is one which should perform 
‘appropriately and in concert with a certain host response in a specific application’[19].  
From this point of view Bioactivation represent the main strategy in modern biomaterial 
development, addressing the adequate direction of the response of the implant to 
external stimuli. Its goal is the development of new types of materials that stimulate a 
biochemical response from living tissue in order to obtain a strong bond  between the 
scaffold and the tissue [20]. Osteocoductive and osteoinductive stimuli may be induced 
by using insoluble signals, via calcium phosphate and, in particular, HA [14] inside the 
implant or by soluble signals represented by proteins, such as growth factor [21] and 
peptide sequence [22].  
Another common belief among many scientists trying to develop new biocompatible 
biodegradable polymers has been that these should be natural molecules or, 
alternatively, analogues of natural polymers, which should release degradation products 
that enter the normal metabolic pathways, rather than being xenobiotic. One first 
approach considered polymers which undergo hydrolytical degradation producing 
metabolites normally present in the physiological environment [23]. Analogs of the 
extracellular matrix have been produced from collagen and glycosaminoglycans which 
are widely and abundantly distributed in the body, but in order to achieve a certain 
stability of the device, it has often been necessary to modify these natural molecules 
chemically. However, in a number of cases concern has been expressed for the potential 
toxicity of some of the crosslinking agents utilized, such as glutaraldehyde, 
formaldehyde and isocyanates [24]. An alternative solution to produce insoluble 
molecules starting from natural components was explored in the mid 1980s and led to 
the development of hyaluronan esters [25]. These novel hyaluronan-based materials 
were obtained by the esterification of the free carboxyl groups of glucuronic acid 
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present along the chain backbone. The current work is aimed at the study of some PCL-
based composites, conceived as substitutes for bone regeneration. Macroporous 
structure were prepared with the salt leaching technique and were analyzed from a 
morphological and mechanical point of view analyzing also their osteoconductive 
properties. 
 
3.2 Materials 
3.2.1 Polycaprolactone (PCL) 
Poly(ε-caprolactone) (PCL) is a biocompatible and biodegradable polyester, widely 
used for biomedical applications. PCL is prepared by ring opening polymerization 
of ε-caprolactone using a catalyst such as stannous octanoate.  
 
Fig. 3.1:Synthesis of PCL by ring opening polymerization of  ε-caprolactone using a catalyst 
such as stannous octanoate. 
 
PCL is a semi-crystalline polymer having glass transition temperature of −60 ◦C and 
melting point ranging between 59 and 64 ◦C, depending upon its crystalline nature 
of PCL [16]. It is soluble in chloroform, dichloromethane, carbon tetrachloride, 
benzene, toluene, cyclohexanone and 2-nitropropane at room temperature. 
 
 
 
 
 
 
 
 
 
CHAPTER 3 Bioactivation of PCL matrices by calcium phosphate solid 
signal 
38 
 
Properties Units Conditions Value 
Molecular conformation - - Nearly planar 
Molecular weight (of repeat unit) g mol-1 - 114 
Weight average molecular weight g mol-1 GPC 74000 
Number average molecular weight g mol-1 GPC 25000 
Intrinsic viscosity Cm3 g-1 Dilute solution 
viscosimetry 
0.9 
Solvents - - DMAc – MDc – 
Thf – benzene 
Entalpy of polymerization kj mol-1 25°C – 1 atm -28.8 
Entropy of polymerization kj mol-1 25°C – 1 atm -53.9 
Gibbs free Energy of pol. kj mol-1 25°C – 1 atm -12.8 
Physical state - semycristalline  
Degree of cristallinity % DSC 69 
Unit cell - X-ray difraction Orthorhombic 
Number of repeating units per unit cell - - 4 
Measured density g cm-3 X-ray diffraction 1.094 – 1.200 
Elongation % - 700 
Glass transitino temperature K DSC 201 
Meltign temperature K DSC 331 
Heat of fusion  kj mol-1 DSC 8.9 
Tab. 3.1 : Physio-chemical PCL properties of special interest. 
 
 PCL can be blended with other polymers to improve stress crack resistance, 
dyeability and adhesion [26]. Degradation of PCL in comparison to polyglycolic 
acid and other polymers is slow making it suitable for long-term delivery extending 
over a period of more than one year. Degradation process is a bulk process that can 
be divided into two phases: (A) molecular weight loss due to chain scission, (B) 
onset of weight loss. No weight loss is observed during the initial phase of the 
biodegradation process, which covers a molecular weight (Mn) range of 200,000 to 
5000. The second phase of polymer degradation is characterized by a decrease in the 
rate of chain scission and the onset of weight loss. Extensive in vitro and in vivo 
biocompatibility and efficacy studies have been performed, resulting in US Food 
and Drug Administration approval of a number of medical drug delivery system 
[27]. At the present PCL is regarded as a soft- and hard –tissue compatible 
bioresorbable material. Although application of PCL might be limited due to its 
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poor mechanical properties, depending on the preparation technique and molecular 
weight.  
 σ (MPa) E (Gpa) ρ (g/cm3) 
PCL 30 0.35 1.13 
Cortical Bone 30 - 160 4 - 27 1.8 – 2.2 
Trabecular Bone 7 – 130 1 – 11 1.5 – 1.9 
Tab. 3.2 : Comparison between typical mechanical properties of PCL and Bone tissue. 
 
Therefore, strategies to improve mechanical performance of PCL-based scaffold are 
needed. Calcium phosphates such as HAP or tricalcium phosphate have been 
employed as bone implant in various form. 
 
3.2.2 Calcium phosphates 
The ability to bond to bone tissue is a unique property of bioactive ceramics.  
Analyses of the bone-implant interface revealed that the presence of hydroxyapatite 
is one of the key features in the bonding zone. Figure 2 schematically summarized a 
variety of events that were reported to occur at the bioactive ceramic-tissue interface 
[28]: (1) dissolution from the ceramic; (2) precipitation from solution onto the 
ceramic; (3) ion exchange and structural rearrangement at the ceramic-tissue 
interface; (4) interdiffusion from the surface boundary layer into the ceramic;  (5) 
solution-mediated effects on cellular activity; (6) deposition of either the mineral 
phase (a), or the organic phase (b), without integration into the ceramic surface; (7) 
deposition with integration into the ceramic; (8) chemotaxis to the ceramic surface; 
(9) cell attachment and proliferation; (10) cell differentiation; and (11) extracellular 
matrix formation  
 
Fig. 3.2: Schematic diagram representing the events which take place at the interface between 
bioactive ceramics and the surrounding biological environment [28] 
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An important aspect of the overall reaction sequence between these materials and 
tissues is that, in the absence of a biologically equivalent, calcium deficient, 
carbonate containing hydroxyapatite (c-Ap) surface upon implantation, dissolution, 
precipitation and ion exchange reactions lead to a biologically equivalent apatitic 
surface on the implanted material. This reaction does not proceed by itself, but is 
accompanied by parallel reactions, such as adsorption and incorporation of 
biological molecules and attachment of surrounding cells. 
Bioceramics can be divided into three broad classification: near-inert, bioactive and 
resorbable. The different tissues reactions elicited by the implant material can be 
partly explained by considering the surface reactions which occur in vivo [19].  
Near-inert ceramics trigger the formation of a thin 1-3µm thick ‘protective’ layer 
absorbed to the surface of the implant. Even if there is no aggressive foreign body 
response, there is no bonding between  implant and host tissue.  
Bioactive materials possess the ability to undergo continuing surface reactions with 
the host tissue, acting in amore natural away. In fact these materials form a chemical 
bond s rapidly with the host tissue and no fibrous layer is formed . Materials that 
exhibit this behaviour are  calcium phosphate.  
Resorbable ceramics present a composition that can be degraded chemically by 
body fluids or digested by macrophages. Really important is that degradation 
products are non-toxicand should be easily disposed of by the cells. Example of 
such materials is tricalcium phosphate that I rapidly resorbed into the body when 
placed in bony defects. This classification is summarized in the table 2: 
Classification Tissue response Examples 
Near inert Formation of non-adherent fibrous membrane Alluminia 
Zirconia 
Bioactive Formation of an interfacial bond Hydroxyapatite 
Resorbable Tissue replaces implant as it degrades Tricalcium phosphate 
Tab. 3.3: Bioceramic classification 
 
Calcium phosphates, specifically hydroxyapatite ceramics, have generated a great 
deal of interest in relation to hard tissue applications due to their bioactivity. 
Calcium phosphate ceramics, such as Hydroxyapatite (HAP) Ca10(PO4)6(OH)2 with 
an atomic ratio of calcium phosphate (Ca/P) of 1.67 or β-tricalcium phosphate (β-
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TCP) β-Ca3(PO4)2, are used for cavity filling applications and work via the 
colonization of the implant by new bone tissue [29]. From a crystallographic point 
of view HAP is more similar to natural bone tissue apatite than β-TCP and so it 
represent a better structural material for bone growth, but the resorption rate of HAP 
is extremely slow as compared with β-TCP [29]. However, due to the poor 
mechanical performance of these materials, clinical usage has been limited to 
applications where calcium phosphate are used either to confer bioactivity or in the 
form of low density ceramic foams, where mechanical performance is not an issue. 
In order to improve the mechanical properties of CPCs, a number of researchers 
have blended polymers with CP cements  with promising results. 
 
3.2.3 Composite materials 
Composite materials often show an excellent balance between strength and 
toughness and usually show improved characteristic compared to their separate 
components. Previous studies have shown that blends of calcium phosphate and 
polymers is a suitable combination to reach high degree of elasticity and a good 
biocompatibility  [14][32]. Different ways were realized to bring these two 
components together into a potential implant, like simple mechanical mixing or co-
precipitation. By special techniques, it is also possible to introduce porosity into the 
implant which is advantageous for most applications as bone substitution material 
[33]. 
 
Fig. 3.3: Some possible combination of calcium phosphates and polymers 
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So a possible strategies to enhance mechanical properties is to reinforce PCL by 
adding hydroxyapatite HAP particles inside the polymer matrix: the presence of 
bioactive solid signals such as HAP in the polymer matrix may improve bone 
formation by osteoblasts mimicking the natural bone mineral phase. Beside the 
osteoconductive enhancement, the inclusion within PCL matrix of rigid bone-like 
particles may improve the mechanical properties of the polymer .  
As well as bioactivation several studies demonstrates that the micro-architecture of 
the porous scaffold may guide cell function by regulating the interactions between 
cell, and the diffusion of nutrient and metabolic wastes throughout the three-
dimensional construct. To mimic the topological and microstructural characteristic 
of the ECM, a scaffold has to present high degree of porosity, high surface to 
volume ratio, fully interconnected porosity, appropriate pore size and geometry 
control. So , in this context, the design and processing of a porous scaffold with a 
suitable morphological characteristic with an appropriate pore size and specific 
surface for cell seeding becomes crucial for the success of these materials as 
scaffolds for orthopaedic applications [4].  
In this chapter porous PCL/HA networks were prepared through phase inversion/salt 
leaching method using NaCl crystal as porogen agent. Stoichiometric HAP 
micrometric particles were chosen for their higher chemically stability. The 
porosity, pore interconnection, and specific surface area, as well as, the mechanical 
properties of the scaffolds, were investigated as a function of the amount of HAP 
particles. Preliminary cellular studies have been carried out using mesenchymal 
stem cells from adult human synovial to assess the potential of the proposed scaffold 
as bone substitutes.  
 
3.3 Methods 
3.3.1 Scaffolds fabrication 
Poly-ε-caprolactone pellets (Sigma Aldrich Mw 65 kDa) were dissolved in a 80wt% 
tetrahydrofuran (Sigma Aldrich, anhydrous ˃99,9%) solution (5g polymer in 20 ml 
tetrahydrofuran) by stirring for about 3h at room temperature. Sodium chloride 
crystals, sieved to a specific range (212-300?m), were homogeneously mixed to the 
polymer solution with a volume ratio of about 9/1. Therefore the mixture was pured 
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in the mold in order to obtain cylindrical specimen with controlled size. Samples 
were dipped in ethanol (20 minutes for 3 times) at room temperature and, finally, 
washed in bidistilled H2O for 7 days. For the hydroxyapatite reinforced scaffolds, 
the HA powder was added to the PCL solution 20 wt% before solvent extraction. 
 
3.3.2 Scaffold morphology analysis: SEM and ?CT 
Scaffold microstructure was investigated by scanning electron microscopy (Leica 
420). Samples were gold-coated using a sputter coater set at 15 mA for 20 min in 
order to perform a qualitative analysis about pore size, distribution and 
interconnection. Furthermore structures have been analyzed from a structural point 
of view using a micro-computed tomography (µCT), (Skyscan 1072 at 10µm 
resolution). Scanning was done at an X-ray tube voltage of 54 kV, a current of 136 
µA and a rotation angle of 180 °C. After reconstruction using the Skyscan software 
thresholded isosurfaces images were obtained. The software was also used to 
generate pore size distribution maps of the structures.   
 
3.3.3 Thermogravimetric analysis 
Thermogravimetric analysis (TGA) was performed to verify the effective weight 
percentage of HAP in the composite scaffold using a TA instrument TGA model 
5000. A nitrogen atmosphere was used with a temperature range from 25 to 700°C. 
 
3.3.4 Mechanical testing 
Compressive mechanical properties were evaluated at room temperature on 
dynamometric machine (Instron ) equipped with a 100N load cell and a crosshead 
speed of 1mm/min. Cylindrical specimen with 2:1 height/diameter ratio (diameter 7 
mm, height 14) were fabricated according to the ASTM 695/2a standard. The elastic 
modulus E was calculated by the initial slope of the stress-strain curve before the 
plateau region. Dynamic-mechanical studies were performed by Bose electroforce 
biodynamic system by superimposing a sinusoidal stress to the specimen and 
recording the related strain.  
Dynamic mechanical Analysis (DMA) can be simply described as applying an 
oscillating force to a sample and analyzing the material’s response to that force [34]. 
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The modulus measured in DMA is, however, not exactly the same as the Young’s 
modulus of the classic stress–strain curve.  Porous cylindrical specimen were 
stimulated under sinusoidal stimulation spanning the frequency from 0.1 to 9 Hz., 
where a pre-load of 0.05 N was initially applied followed by a dynamic load of 1N. 
From these data we can calculate the storage or elastic modulus E’ and the loss 
modulus E’’ as follow: 
• E’ = (σ0/ε0)cosδ 
• E’’ = (σ0/ε0)sinδ 
 
3.3.5 Preliminary biological evaluation 
Multipotent mesenchymal stem cells from human synovial membrane were used for 
biological evaluation of PCL/HAP composite macroporous scaffolds. Random 
biopsies of SM (wet weight 10–50 mg) were obtained aseptically from the knee 
joints of one human donors  (16 years old). As comparison HMSc from a male 
donor (4 years old) were obtained to test the difference in cell capability to express 
the osteoblastic phenotype. Synovial sample was diluted 1:1 with OptiMem 
(Invitrogen) culture medium supplemented with 10% FBS, antibiotic (100 ?g /ml 
penicillin, 100 ?g /ml streptomycin) and fungizone (250 ?g/ml) as antimycotic.  
Following overnight incubation at 37°C in humidified atmosphere 5% CO2, cells 
were collected by centrifugation 800 r.p.m for 15 min, washed twice. Plated in a 
culture flask and allowed to attach for 48 hours. Non adherent cells were removed 
and cellular suspension were centrifuged for 10 min at 800 r.p.m to recover the 
culture medium. The medium was replaced every 3 days. After 2-3 weeks of 
primary culture, when the sparsely attached cells reached confluence, they were 
washed twice with calcium and magnesium–free phosphate buffered saline (PBS), 
harvested by treatment with trypsin and replated at a 1:4 dilution for the first 
subculture. Cell passages were continued in the same way with a 1:4 dilution when 
cells reached confluence. The next step was to verify cells capability to express 
markers of different phenotype like adipocytic and osteoblastic. The in vitro 
adipogenesis assay was performed as described elsewhere (2). SM-derived cells 
were allowed to become confluent and were cultured for an additional 5 days. 
Adipogenic induction medium was then added, consisting of growth medium 
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supplemented with 1 mM dexamethasone, 0.5 mM methyl-isobutylxanthine and 10 
mg/ml insulin, (all from Sigma). Cells were treated 4 times with adipogenic 
induction medium. The cultures were then maintained in adipogenic maintenance 
medium for 21 days before fixation, and microscopic observation. 
 
Fig. 3.4: microscopic images of SM-derived cells cultured for 21 days with adipipogenic 
induction medium (A) and after treatment with Sudan III 
 
To verify the in vitro osteogenic expression SM-derived cells were cultured for 21 
days with growth medium supplemented with 100 nM dexamethasone, 10 mM b-
glycerophosphate, and 50 mM ascorbic acid.  
 
Fig. 3.5: micrographic images of SM-derived cells after 21 days treatment with normal medium 
(A) and osteogenic medium (B) 
 
As control part of the SM-derived  cells were cultured in normal growth medium as 
we can see in figure 
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3.4 Results and discussions 
3.4.1 Scaffold morphology analysis: SEM and ?-CT 
Porous PCL/HAP scaffolds obtained by phase inversion/salt leaching method were 
characterized by SEM micrographs of the surface. A typical topology of PCL/HAP 
scaffold was outlined in figure : 
 
 
Fig. 3.6: Microporosity of PCL/HAP -based composite scaffolds by SEM analysis. Micropores 
along section surface. 
 
As a consequence of the dispersion of NaCl crystals with well-controlled size inside 
the PCL matrix and an intimate contacts between crystals, the proposed technique 
guarantees an adequate pore size range and a high degree of interconnection of 
pores. Indeed, as evidenced by SEM observations, the obtained scaffolds were 
characterized by a regular structural porosity with homogeneously distributed and 
well-interconnected pores. It can be clearly seen that all scaffolds have the two 
distribution peaks of the smaller and bigger pores at around 5–20 ?m and 200–400 
?m, respectively. Phase inversion process led to the formation of small pores 
(smaller then 20?m), while the removal of NaCl led to the formation of big pores 
(bigger than 100 ?m). Figure 6 shows the surface topography of the pore wall in 
PCL/HAP scaffolds. It was also necessary to have a quantitative information about 
the different elements present inside the scaffold. This is accomplished by using the 
“built-in” spectrometer called an Energy Dispersive X-ray Spectrometer. Energy 
dispersive X-ray analysis, also known as EDS, EDX or EDAX, is a technique used 
to identify the elemental composition of a sample or small area of interest on the 
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sample. To explain further, when the sample is bombarded by the electron beam of 
the SEM, electrons are ejected from the atoms on the specimens surface.  
 
Fig. 3.7: Qualitative evaluation of P and Ca peaks by energy dispersive spectroscopy analysis 
on the cross section. 
Element Weight (%) Atomic (%) 
C 59.35 68.39 
O 33.34 28.85 
P 2.30 1.03 
Ca 5.01 1.73 
Tab. 3.4: elemental composition of the cross section area. 
 
The  EDS x-ray detector measures the number of emitted x-rays versus their energy. 
The energy of the x-ray is characteristic of the element from which the x-ray was 
emitted. A spectrum of the energy versus relative counts of the detected x-rays is 
obtained and evaluated for qualitative and quantitative determinations of the 
elements present. The energy dispersive spectroscopy analysis performed on the 
cross section of HAP-loaded scaffolds (Fig. 6) confirmed the presence of the apatitic 
phase: two large peaks due to Ca and P elements were observed, and a Ca=P atomic 
ratio about 1.66, that is, very close to the theoretical value of stoichiometric HAP 
(Ca=P¼1.67), was calculated. Because the completely unpredictable structure inside 
the scaffold pores and pore inteconnectivity can be difficult to assess, but the use of 
micro-computed tomography (µCT) allows for a more precise definition and better 
assessment of scaffold characteristic. Structures were analyzed from a quantitative 
point of view using a micro-computed scanning (?CT) to observe the microstructure 
of materials in 3D. Three-dimensional (3d) image analysis techniques are used to quantify 
distribution properties of the 3d microstructure of such partly scaffolds.   After 
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reconstruction using the Skyscan software thresholded isosurfaces images were 
obtained. 
 
Fig. 3.8:pore size distribution of PCL/HAP scaffold from ?-CT analysis. The bars in the 
histogram correspond to volume fraction of pores with specific diameters 
 
From the ?CT data, the structural parameters of the built scaffold were determined 
and summarized in table : 
 
Sample Porosity (%) Specific surface area (mm-1) Pore size (µm) 
PCL 74,6 ± 3,2 49,5 ± 6,7 181 ± 18 
PCL/HAP 72,5 ± 4,3 41,3 ± 3,18 172 ± 15 
Tab. 3.5: Parameters of the built porous structures as determined by ?-CT 
 
The results indicate that the scaffold porosities are around 70–75%, which is 
considered to be beneficial for cell in-growth. Porosity seems to be unaffected from 
the HAP particles as it is to recognize from the comparison between PCL and 
PCL/HAP scaffolds. Among the morphological characteristics, a crucial aspect for 
cell adhesion and then proliferation is represented by the specific area of the 
substrate. In particular, since the surface area could modify important functional 
features such as the mechanism of cell adhesion and the rate of degradation, the 
surface/volume ratio (S/V) was investigated. It was obtained from the µCT-data and 
a high value of  37.9 mm2/mm3 was determined for this scaffolds. 
 
3.4.2 Thermogravimetric analysis 
Essential statement regarding the thermal stability of a composite are obtained from 
the thermogravimetric (TGA) and analyses. Thermogravimetric curves (TGA) of  
PCL and PCL composite are given in Figure . Thermal decomposition of each 
sample takes place in a programmed temperature range of  30-700ºC. In the case of 
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PCL we have only one weight loss between 350 and 425 ºC due to the polymer 
degradation. For the composite material it is possible to recognize the same weight 
losses seen for the previous sample but also there are a certain percentage of 
material that doesn’t degrades over 700 ºC. This mass retain over 700 ºC is due to 
the presence of HAP that is the mineral phase and doesn’t degrade until 1000 ºC. 
 
Fig. 3.9:TGA of PCL and PCL/HAP composite scaffold. 
 
3.4.3 Mechanical testing 
The mechanical properties of porous scaffolds are evaluated by compressive tests. 
The mechanical properties of PCL, PCL/HAP scaffolds are shown in Figure . 
Compared with the pure PCL scaffold, composite scaffolds exhibit higher 
compressive modulus. The compressive modulus of PCL/HAP scaffold increases 
from 0.075 to 0.20 MPa while the compressive strength increases from 25 to 52 Pa 
as the filler content increases from 0 to 20 wt%. The improvement in elastic 
modulus and strength could be attributed to the enhancement of the interaction 
between filler and matrix and a better dispersion of filler in the matrix. The static 
compression tests enabled to obtain the stress/strain curve of composite scaffolds. 
Firstly, it describes the mechanical behaviour of porous systems under static 
conditions: it shows a linear elasticity at low stresses followed by a long collapse 
plateau truncated by a regime of densification in which the stress rises steeply. The 
elastic modulus E was calculated by the initial slope of the stress-strain curve before 
the plateau region. 
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Fig. 3.10: stress/strain curve  for PCL and PCL/HA scaffolds. Composite scaffold shows an 
high elastic modulus . 
 
 
 
 
 
Tab. 3.6 : Static compression test evidence the difference in mechanical response between PCL 
and PCL-HAP composite scaffold. 
 
The definition of the elastic range allowed to establish the  average load and 
amplitude to apply for the cyclic stimulation. Specimens were tested under the stress 
control mode, where a pre-load of 0.05 N was initially applied followed by a 
dynamic load of 1N. The evolution of elastic moduli was evaluated varying the 
frequency from 0.1 to 9 Hz.  
Dynamic tests confirm the result obtained by static compressive test, showing  an 
higher value of E’ for the PCL/HAP samples. Moreover the test highlights a certain 
viscoelastic behaviour of the samples showing that E’ increases with frequency, 
while loss modulus E’’ is not significantly affected as frequency varies. 
 
 
Sample 
σmax (elastic region) 
(MPa) 
E 
(Gpa) 
εmax (elastic region) 
(MPa) 
PCL 0,13±0,003 0,075±0,004 0,421±0,02 
PCL/HAP 0,30±0,003 0,20±0,024 0,405±0,03 
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Fig. 3.11:evaluation of Storage modulus (E’) and loss modulus (E’’) through DMA for PCL and 
PCL-HA porous structure 
 
3.4.4 Biological evaluation 
Scaffolds were prepared to cell seeding with two different methods: one part were 
sterilized by ethylene oxide and the others washed with antibiotic/antymicotic PBS 
solution. Ethylene oxide acts more strongly against bacteria, especially gram-
positive bacteria, than against yeast and fungi. The disinfectant effect of ethylene 
oxide is similar to that of sterilization by heat, but because of limited penetration, it 
affects only the surface. The Sterility Assurance Level, after a certain specified 
exposure to ethylene oxide is 10−6, meaning that the chance of finding a single 
bacterium is below 1 per million. The remaining part of the scaffolds were soaking 
in ethanol overnight and then 1% antibiotic/antimycotic  in PBS for 2 days. After  
they were extracted from the solution and washed in PBS for 1 day to remove 
antibiotic/antimycotic traces and prewetting in medium for 3 days. Human 
synovium MSCs were seeded dropwise 15 x 104 per sample on 12 samples and 
allowed to settle on the  surface for 30 min; 3 scaffolds were soaked in osteogenic 
medium without cells as control.  Then 200 ?l of medium were added to the wells. 
The seeded scaffolds were cultured in osteogenic medium for 14 days, with media 
exchange every three days.  After 3 days culturing, scaffolds were assayed for cell 
viability using MTT assay alkaline phospahatase content was measured every 7 days 
using the alkaline phosphatise kit and observed by SEM as detailed elsewhere.  
The MTT assay is a colorimetric assays that allows to assess the viability (cell 
counting) and the proliferation of cells (cell culture assays). The MTT calorimetric 
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assay determines the ability of viable cells to convert a soluble tetrazolium salt 3–
(4,5-dimethylthiazol-2l)-2,5-diphenyltetrazolium bromide (MTT) into an insoluble 
formazan precipitate. Tetrazolium salts accept electrons from oxidized substrates or 
appropriate enzymes, such as NADH and NADPH. In particular, MTT is reduced at 
the ubiquinone and cytochrome b and c sites of the mitochondrial electron transport 
system and is the result of succinate dehydrogenase activity. This reaction converts 
the yellow salts to blue-colored formazan crystals that can be dissolved in an 
organic solvent whose concentration can be spectrophotometrically determined by 
optical density at 570 nm. 
Culture medium were removed from the well and cells were washed with PBS 
(Sodium phosphate 10 mM, pH 7.4, NaCl 120 mM – KCl 2.7 mM). 
 
Fig. 3.12:MTT assay at 3 (A) and 7 (B) days after seeding,  with relative absorbance  value 
 
Absorbance shows an high increase between 3 and 7 days if  compared with the 
control peak, this would suggest that 3D matrices are colonized by a very high 
number of proliferating cells, moreover synovial liquid MSC show higher value of 
absorbance if compared with HMSc. 
ALP (Alkaline phosphatase) activity through colorimetric assay (Roche kit) was 
used as an indirect measure of the capacity to hydrolyze inorganic phosphate. The 
enzyme assay kit is based on the alkaline phosphatase (ALP)-mediated conversion of p-
nitrophenol phosphate to nitrophenol in an alkaline buffer. P-nitrophenyl phosphate is 
colourless while p-nitrophenol shows a yellow colouring in alkaline environment and it 
exhibits an absorption maximum at 405-415 nm. The is used to examine cell differentiation 
such as osteogenesis, which is associated with increased expression of ALP. The production 
of p-nitrophenol in the presence of ALP was measured by monitoring light absorbance by 
the solution at 405 nm. Results are expressed as u/(mg protein). 
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Fig. 3.13: ALP release by cells grown onto PCL-HA samples for different time periods. 
 
Preliminary results at 14 days shows an increase in ALP activity suggesting an 
increased osteoblast differentiation. High-resolution morphological techniques, 
SEM imaging, led us to observe the spreading and growth of cells onto materials.  
 
Fig. 3.14: SM-derived cells spreading onto micro/macroporous PCL at  2 weeks: cells are elongated, 
connected to each other and a few enter the macropores 
 
At 2 weeks Cells were multilayered with evident cytoplasmic filopodia providing 
intercellular communication, and a consistent extracellular network underneath. 
SEM images reveal that many anchoring processes were observed extending from 
cells to the biomaterial surface, as well to other cells. Cytoplasmic prolongations 
going deeper in the pores of the polymeric matrix are observed.  
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Fig. 3.15:  for higher magnification it’s possible to seethe formation of cell layer on Scaffold’s 
surface. 
 
At higher magnification it’s possible to notice the formation of a cell layer on PCL 
evidences a significant proliferation of adhered cells up to 2 weeks, and the release 
of alkaline phosphatase, is consistent with osteoblastic maturation on the scaffolds.  
 
3.5 Conclusions 
We have developed a method of producing three dimensional, open-cell, composite 
foams of PCL and hydroxyapatite particles.  The composite scaffolds with porosity 80% 
were fabricated using PI/SL (phase inversion/salt leaching) method. This method allows 
efficient exposure of HAP at the surface of polymer/bioceramics composite scaffold as 
Sem analysis show. So PI/SL scaffolds can increase the chances of osteogenic cells to 
make contact with the bioactive ceramics, which enhances osteoblast differentiation and 
growth. Moreover composite scaffolds exhibit enhanced mechanical properties showing 
higher compressive moduli as compared to the PCL scaffolds. It was found that by 
incorporating 20 wt% HAP in the scaffold, the compressive modulus increased from 
0.07 of the PCL sample to 0.2 MPa. So the mechanical strength was found to be 
dependent on the filler in the scaffold while porosity and thermal property of the 
scaffolds seem to be not much affected from HAP particles as SEM images and ?-CT 
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analysis demonstrate. Although the PCL/HAP composite scaffolds showed higher 
mechanical properties, as compared with the PCL scaffolds, the measured compressive 
moduli of the prepared scaffolds is rather low compared to that of human bone. This 
might be due to the highly porous structure of the fabricated scaffolds and the poor 
mechanical properties of the PCL itself, even after reinforcement with HA. Therefore, 
the fabricated scaffold could be applied in non load-bearing parts. More importantly, the 
composite was developed not only to improve enhance the mechanical properties but 
also to improve the overall biological response to the scaffold by creating a bioactive 
substrate that could ultimately integrate with bone tissue. Cellular response and 
bioactive potential of the 3-D, porous composite were evaluated in vitro by culturing the 
scaffold with human sinovium-derived MSCs for to 2 weeks. It was found that the 
PCL/HAP composite scaffolds supported the synthesis of alkaline phosphatase, in 
addition to the adhesion and proliferation of Human Sinovium-derived MSCs. 
Furthermore, encouraging results are reached  in the comparison between human bone 
marrow MSCs and MSCs from human-sinovial membrane. SM-derived cells treated 
with osteogenic medium underwent a change in their morphology from spindle shaped 
to cuboidal, (Figure 4A and 4B) and formed large nodules after 21 days and increased 
over time. Furthermore they  were found more active on the composite, due to a higher 
value of absorbance in the MTT assay.  
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CHAPTER 4 
HYAFF11® loaded scaffolds for Bone regeneration. 
 
4.1 Introduction 
4.1.1 Design of multifunctional scaffolds 
Permanent implants into tissue almost always elicit a chronic inflammation called a 
foreign body response. This response is characterized by formation of a poorly 
vascularised fibrous layer analogous to a scar at the material tissue interface. The 
foreign body response is typically benign and sometimes desirable to anchor devices 
into host tissue, but leads to enough clinical complications (e.g. infection, tissue 
contraction) that it is considered a risk to be avoided if possible in many 
applications [1][2].  It is obvious from the recent literature on clinical engineering 
that there is an increasing interest in resorbable biomaterials with specific biological 
properties and good biocompatibility profiles that resorb or degrade in body fluids 
so that the device ultimately disappear with no ill effects [3][4]. Much of this 
interest has been stimulated by recent breakthroughs in tissue-engineering 
techniques, where resorbable scaffold materials are used as a support matrix or as a 
substrate for the delivery of cultured cells or for three-dimensional tissue 
reconstruction [5]. In this context  the syncronization of polymer degradation with 
its replacement by natural tissue produced from cells would be desiderable [6]. The 
influence of several factors on degradation kinetics may be considered, including 
molecular factors (e.g. chain orientation, molecular weight, and polydispersity), 
supramolecular factors (cristallinity, the spatial distribution of chemically reactive 
filler) and environmental factors (mechanical stimuli) to potentially generate wide 
range of resorbable properties for custom-made system.  So the degradation 
properties of a scaffold are relevant both to the biomaterial design and to the long-
term success of a tissue engineered construct [7]. Biodegradable synthetic polymers 
offer a number of advantages over other materials for developing scaffolds in tissue 
engineering [8] and they have been used in a number of clinical application. Among 
the families of synthetic polymers, the polyesters have been attractive for these 
applications because of their ease of degradation by hydrolysis of ester linkage, 
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degradation products being resorbed through the metabolic pathways in some cases 
and the potential to tailor the structure to alter degradation rates. Over the last two 
decades, biodegradable polyesters, such as poly(lactic acid) PLA, poly(glycolic 
acid) PGA and poly(ε-caprolactone) PCL, have emerged as a class of biomaterials 
of growing interest for application in surgery, drug delivery and tissue engineering 
[9][10]. They exhibit predictable and reproducible mechanical and physical 
properties, such as tensile strength, elastic modulus and degradation rate under 
controlled conditions [11]. A key consideration in scaffold design is that the 
complex composition and structural organization of hard mineralized tissues, such 
as bone, cannot be replicated using a single material offering a limited range of 
properties [12]. In particular, scaffolds for bone regeneration have to provide a 
highly interconnected porous structure to guide cell in growth for tissue formation, 
whereas maintaining a sufficient mechanical strength to supply the structural 
requirement of the substituted tissue [13]. To date, the employment of composite 
materials may be a good solution, achieving the ideal balance between strength and 
toughness due to the improvement of specific characteristics of the composite 
compared to its separate components [14]. However, the need of scaffold materials 
to be porous, biocompatible and biodegradable, and to exhibit a degradation or 
resorption rate similar to the rate of tissue replacement, is often in conflict with the 
possession of adequate mechanical properties able to match those of the tissues at 
the site of implantation [15]. To date, several studies have examined the use of 
bioceramic particles such as silica, HA or other calcium phosphates in combination 
with biodegradable polymers like poly ε-caprolactone (PCL) to produce bone 
substitutes  [14]. However, most results taken from previous studies reveal that, 
while the incorporation of a ceramic phase improved the bioactivity of the 
polymeric scaffold, this advantage is not usually combined with a commensurate 
enhancement of the mechanical properties of the composite [16]. Recently, Guarino 
et al. [12] proposed an alternative composite tubular structure. This is obtained by 
the merging of a PCL matrix with continuous fibres of PLLA helically wound by 
the filament winding technique. By applying the basic theory of continuous fiber-
reinforced composites to the scaffold design, a composite material has been 
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developed with an optimal spatial organization of fibers within the polymer matrix, 
able to mimic the structural organization and performance of the living tissue.  
One common belief among many scientists trying to develop new biocompatible 
biodegradable polymers has been that these should be natural molecules or, 
alternatively, analogues of natural polymers, which should release degradation 
products that enter the normal metabolic pathways, rather than being xenobiotic. 
One first approach considered polymers which undergo hydrolytical degradation 
producing metabolites normally present in the physiological environment [23]. 
Analogs of the extracellular matrix have been produced from collagen and 
glycosaminoglycans which are widely and abundantly distributed in the body, but in 
order to achieve a certain stability of the device, it has often been necessary to 
modify these natural molecules chemically. However, in a number of cases concern 
has been expressed for the potential toxicity of some of the crosslinking agents 
utilized, such as glutaraldehyde, formaldehyde and isocyanates [24]. An alternative 
solution to produce insoluble molecules starting from natural components was 
explored in the mid 1980s and led to the development of hyaluronan esters [19]. 
Hyaluronan-based polymers applied to tissue defects provide an appropriate 
scaffolding and favourable microenvironment for the regeneration process. the 
integration of highly degradable materials, obtained by chemical modification of 
purified hyaluronan (HA) namely HYAFF11®, formed by the partial or totally 
esterification of carboxyl group of glucuronic acid provides the opportunity to affect 
directly the cell activities, favouring the adhesion of certain cell types [23][20][21]. 
Here, partially esterified HYAFF11® (esterification degree 75%) has been selected 
for its optimal hydrophilic/hydrophobic character which confers an adequate 
biological recognition and it has been used in combination with a composite 
scaffold obtained by incorporating poly(L-lactide) (PLLA) continuous fibers within 
a PCL matrix through the synergic combination of phase inversion/salt leaching 
technique and the filament winding technology. The combination of phase inversion 
with salt leaching assures highly porous structures with a pore volume fraction 
exceeding 80% of total volume and a bimodal pore distribution [22] , while filament 
winding technology is a powerful instrument to produce composite polymers with 
improved mechanical response in compression  and tailored degradation kinetics 
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[6]. In addition to fibre reinforced scaffolds polymeric composite structure of PCL 
and ester of hyaluronic acid have been prepared with the salt leaching/phase 
inversion technique encouraging by the biological result which similar system have 
exhibited as in vivo scaffold for tissue regeneration.  
A morphological investigation involving the porosity assessment was performed by 
using scanning electron microscopy, and micro computer tomography analysis (?-
CT), whereas the degradation kinetics was investigated by  thermogravimetry 
(TGA). Mechanical properties were assessed trough static and dynamic mechanical 
tests while in vivo tests were performed in collaboration with Orthopaedic institute 
Rizzoli in Boulogne  as preliminary studies of material-tissue interactions. 
  
4.1.2 Biodegradable polymers 
Degradable polyesters derived from three monomers lactide, glycolide, and 
caprolactone are in common clinical use and are characterized by degradation times 
ranging from days to years depending on formulation and initial Mw. Over the last 
two decades biodegradable polymers, such as poly(lactic acid) PLA, poly(glycolic 
acid) PGA and poly(ε-caprolactone) PCL, belonging to the family of poly(α-
hydroxyesters), have emerged as a class of biomaterials of growing interest for 
application in tissue engineering. With the exception of polyglycolide (PGA), the 
polymers in this family are soluble in many common organic solvents and thus can 
be processed by a variety of thermal and solvent-based methods [23]. They are 
insoluble in water but degrade by hydrolytic attack of the ester bond. Many studies 
suggests that these polymer are sufficiently biocompatible, non toxic and non-
inflammatory. Because of their chemical and structural similarities, they degrade in 
similar way through ester hydrolysis processes and decarboxylation from the chain 
ends, assuring their complete removal from the body.  
PLA is present in three isomeric forms d(-), l(+) and racimic (d,l) and the polymers 
are usually abbreviated to indicate the chirality. Poly(l)LA and poly(d)LA are semi-
crystalline solids, with similar rates of hydrolytic degradation. For most application 
the (l) isomer of lactic acid is chosen because it is preferentially metabolized in the 
body. PLA degrades through random  hydrolysis of their ester bonds to form lactic 
acid which is normally present in the body. This acid then enters tricarbolxylic acid 
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cycle and is excreted as water and carbondioxide. The rate of degradation however 
is determined by factors such as configurational structure, copolymer ratio, 
cristallinity, molecular weight, morphology, stresses, amount of residual monomer, 
porosity and site of implantation [24][25]. PCL is a semycristalline polymer with a 
glass transition temperature of about -60°C. The polymer has a low melting 
temperature (59 to 64°C) and is compatible with a range of other polymers. PCL 
shows a remarkably slow degradation rate – from 6 months up to 3 years for its 
complete removal form the host body – as a function of the starting molecular 
weight [26][27]. The long-term degradation follows a two-step mechanism: a 
random hydrolytic ester cleavage and weight loss through the diffusion of 
oligomeric species from the bulk  Firstly this preserve mechanical integrity over the 
degradation lifetime of the devices, so allowing adequate mechanical support during 
the post-implantation period. Secondly  the absence of toxic response assures bone 
ingrowth into the porous scaffold [6]. In the recent history of biompolymers, 
different molecular engineering have led to the development of a variety of modified 
natural polymers aimed at reaching the highest level of compatibility in the 
physiological environment [28]. HA could certainly find additional uses, 
particularly in the biomaterials field, but some physical and biological 
characteristics of hyaluronan in its purified form, such as water solubility, rapid 
resorption and short residence time in the tissue, limit its possible applications. For 
this reason, several attempts have been made to modify its molecular structure to 
obtain a more stable solid material. An alternative  solution to produce molecules 
starting from natural component was explored in the 1980 and led to the 
development of hyaluronan ester [29][23]. Cross linking and coupling reaction were 
two of the ways considered to obtain a modified stable form of HA. In particular our 
attention has been focused on HYAFF®, another class of hyaluronan derivate 
polymers obtained by a coupling reaction. This esterification reaction  improve the 
stability of the polymer without altering so much its biological characteristic [30]. 
This chemical modification acts both by reducing  the hydrophilic, negatively 
charged, carboxyl groups and increasing its hydrophobic components.  
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Fig. 4.1: The structure of the total benzylic hyaluronan ester Hyaff®11.  [30] 
 
It was found that the higher the percentage of esterification of hyaluronan, the lower 
its solubility in water. Examining in detail the properties of benzyl and ethyl HA, 
the derivatives where 100% of the carboxyl groups are esterified (benzyl and ethyl 
total esters), it emerges that they are insoluble transparent materials which can be 
extruded into thin membranes [31]. Examining the materials behaviour in aqueous 
solution, the total benzyl ester (HYAFF®11) showed only slight hydration when 
placed in buffered phosphate saline solution. In the case of 75% hyaluronan benzyl 
and ethyl esters (respectively HYAFFA' 11p75 and HYAFF' 7p75) hydration was 
even greater, reaching up to 1250% of weight increase with respect to the dry 
conditions [23]. In this work partially esterified HYAFF®11p75 (esterification 
degree equal to75%) has been used for its optimal hydrophilic/hydrophobic 
character which confers an adequate biological recognition, without drastically 
penalizing the structural integrity of the composite scaffold.  
 
4.2 Materials and Methods 
4.2.1Materials 
Poly(ε-caprolactone) (PCL, MW 65 kDa) and PLLA fibres (75 D-tex) were 
purchased, respectively, from Sigma–Aldrich and Sofradim companies. A benzyl 
ester of hyaluronic acid with 75% of esterification degree (HYAFF11®-75p) 
supplied by Fidia Advanced Biopolymers in powder form. Tetrahydrofurane (THF) 
and dimethylsulfoxide (DMSO) have been purchased from Sigma Aldrich . Sodium 
chloride crystal (Fluka AT>99.9%) were sieved in specific size range depending on 
scaffold type (212-300?m and 300-500 ?m). A mixture of Ca2NaK(PO4)2 (CSPP) 
and, monocalcium phosphate monohydrate (MCPM) were supplied by Technical 
Univeristy of Catalunia (UPC) under the name of R-cem. 
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4.2.2 Fibres reinforced scaffold preparation 
Poly ε-caprolactone pellets (MW 65 kDa) were dissolved in a solvent mixture to 
form a solution by stirring for 3 h at room temperature using a PCL/solvents ratio 
equal to 12/88 wt/wt. Two different solvents were used, respectively, 
tetrahydrofurane  and dimethylsulfoxide by 80/20 weight ratio. HYAFF11 was then 
mixed to the polymer solution imposing a PCL/HYAFF11  weight ratio equal to 
80/20. NaCl crystals with specific size ranges (300-500?m) were employed as 
templating agents and  the PCL/NaCl volume ratio(32/64 v/v) was selected in order 
to optimize the fibre/matrix adhesion.  Finally fiber reinforced composite scaffold 
(PHF) were obtained by combining the phase inversion/salt leaching and filament 
winding technology. Briefly, PLA fibres impregnated through the PCL/HYAFF11 
solution, were wound on a polypropylene tubing coated stainless steel mandrel with 
1 mm diameters by using a specific winding parameters set (winding angle WA = 
45°, winding pitch WP = 500 ?m). In order to improve the surface finishing and to 
give a more regular shape to the  scaffold, a teflon round  mold has been employed 
as showed in figure 2.  
 
Fig. 4.2: Scheme of the filament winding procedure used to prepare PLLA fibre-reinforced 
scaffolds 
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Once tubular shaped scaffold was obtained, conventional procedures involving 
ethanol and water washings, for 24 h and 7 days, samples with 5 mm as outer 
diameter and 10 mm as height were employed for morphological and mechanical 
characterization. For the in vivo test PHF samples have been employed with the 
following dimension: 16 mm as outer diameter, 4 mm as inner diameter and 20 mm 
as height taking care to the external surface finishing. 
 
Fig. 4.3: comparison of unrefined (A) and refined (B) surfaces of PCL/PLLA scaffolds. 
 
4.2.3 Calcium phosphate composite scaffolds preparation. 
Poly ε-caprolactonepellets (MW 65 kDa) were dissolved in a THF/DMSO (80/20 
wt/wt) solution by stirring for 3 h at room temperature. The benzyl ester of 
hyaluronic acid (HYAFF11 - 75p) in powder form was then mixed to the polymer 
solution imposing a PCL/HAYFF11 weight ratio equal to 80/20 (wt/wt). NaCl 
crystal with specific size ranges (212-300?m)were employed as templating agent by 
using a PCL/NaCl weight ratio equal to (1/9 wt/wt). Furthermore, a mixture of of 
Ca2NaK(PO4)2 (CSPP) and, monocalcium phosphate monohydrate (MCPM) under 
the name of R-Cem have been used as reinforcing agent.  
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Fig. 4.4: scheme of the salt leaching/phase inversion tecnnique used to prepare 
PCL/HYAFF11/R-Cem composite scaffolds. preparation 
 
Two different PCL and HYAFF11 scaffold based composite have been prepared 
with the salt leaching/phase inversion technique, labelled respectively as PHS and 
PHRS. The PHS type was developed from the PCL/HYAFF11 solution described 
above. After NaCl crystal incorporation  the mixture was placed into Teflon moulds 
reproducing the final cylindrical shape, 5 mm as diameter and 10 mm as height, of 
the scaffold. Finally, ethanol washing for 24 h at room temperature were performed 
to completely extract the used solvents whereas daily washing in bi-distilled water 
for 7 days were used to leach out NaCl crystals as well to remove other 
contaminants. 
 
4.2.4 Morphological investigation by SEM and ?-CT analysis 
Scaffold morphology was investigated via Scanning Electron Microscopy using a 
scanning electron microscope (Stereoscan 440, Leica, UK). Briefly, specimens were 
cut using a razor blade along preferential directions, parallel and perpendicular to 
the surface, respectively. The resulting transverse and longitudinal sections were 
gold-coated under vacuum by using an automatic coating sputter set at 15 mA for 
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about 20 min (Emiscope SC500, Italy). The porosity was assessed in terms of pore 
size, shape and spatial distribution by images at different magnifications. Structural 
analysis waas performed by micro-computed tomography (?CT) using a Skyscan 
1072 scanner at 11.1 ?m resolution . Scanning was done at X-ray tube voltage of 54 
kV and a current of 136 ?A. 
After reconstruction using Skyscan CT-analyser and CT-Volume software, 
thresholded isosurfaces images were obtained. The software was also used to 
generate pore size distribution maps of the structures. The maps were used to 
calculate porosities and pore size distribution.  
 
4.2.5 Thermal analisys 
The DSC thermograms were performed by a DSC Q20 (TA Instruments) equipped 
with a nitrogen cooling unit. All measurements were performed in a helium 
atmosphere using standard crimped aluminum pans. Samples, with average weights 
of 2 mg, were scanned at a heating rate of 10 °C min till 250°C. Four type of 
samples were analyzed: PS, PHS, PHRS, PHF. The melting temperature, Tm,and 
the enthalpy of fusion were determined from the peak value of the endotherms peak.  
Thermal gravimetric analysis (TGA) was performed on a TA Instrument Q 5000 
under nitrogen atmosphere, from room temperature up to 700 °C, with a heating rate 
of 10 °C/min.  
 
4.2.6 Mechanical properties of porous structures 
Mechanical test in compression was done using a dynamometric machine (Instron 
4204) equipped with a load cell of 1 kN and requiring a crosshead speed of 
1mm/min. Porous cylindrical specimens characterized by a height of 10 mm and a 
diameter of 5 mm were fabricated according to the ASTM 695/2a standard. The 
stress and modulus response to strain were recorded. The elastic modulus E’ has 
been calculated as the slope of the tangent to the initial linear portion of the 
deformation curve. Dynamic mechanical analysis (DMA) was performed using a 
Bose Electroforce Biodynamic system applying a sinusoidal stimulation on the test 
specimen. The DMA results are presented in terms of three main parameters: 
storage modulus (E’), loss modulus (E’’), and mechanical loss tangent (tan δ). The 
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cyclic stimulation was originated by a sinusoidal stress with dynamic amplitude of 
0.5 N spanning the frequency from 0.1 to 6 Hz in order to simulate the native 
microenvironment of bone tissue. 
 
4.2.7 In vivo test 
Three different sample typologies have been used for the in vivo test PHRF (PCL/hyaff/R-
Cem + PLLA fibres) , PHRF with PRP (Platelet rich Plasma) and BMSCs (Bone marrow 
mesenchimal stem cells), PHRF with BMP7. Implants were cut in cylindrical shape with the 
following dimension: 20mm length, 16 mm external diameter and 4 mm internal diameter 
and were sterilized with ethylene oxide.  
 
Fig. 4.5: Shape and sterilization procedure for the PHF scaffolds used in the in vivo test. 
 
A 20mm critical-size bone defect was created in the sheep metatarsal bone and 
scaffold was impanted. An osteosynthesis stainless plate to stabilize the site of 
fracture. Rabbits were anesthetized by intramuscular injection of a mixture of 
ketamine hydrochloride  and xylazine. The metatarsal bone was exposed any 
bleeding was carefully controlled. All debris was removed from the defect with a 
curette, and the edges were carefully refined. The implants were then pressfit into 
the defect and the fracture site was stabilized by the stainless steel plate. The skin 
was closed with double with a continuous 4-0 dexon suture. 
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Fig. 4.6: PHF scaffold’s implantation in a 20mm critical-size bone defect in the sheep 
metatarsal. 
 
Ships  were euthanized at  12  weeks after surgery by intravenous overdose of 
sodium pentobarbital. The implants were removed and they were then dehydrated in 
graded series of alcohols until the absolute was reached. They were stained with 
Fast Green and  acid fuchsin and were processed for routine histological and 
histomorphometric analyses by using a transmission and polarized light Microscope 
at various different magnification. To determine bony ingrowth within a certain 
frame of time, all animals received a polychrome sequential labeling with 2 different 
spectrophotometric methods. Alizarin red and Xylenol in order  to confirm the 
osteogenic activity.  
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4.3 Results and discussion 
4.3.1 Scaffold morphology 
The preliminary investigation of the structural architecture of composite scaffolds was 
made by SEM. In each case, high structural porosity, characterized by a bimodal pore 
size distribution, was observed. In the case of PHS and PHRS, cross-section images 
indicate a homogeneous spatial distribution of macropores of undefined shape and with 
sizes ranging from 150 to 400 ?m.  
 
Fig. 4.7: Microporosity of PCL/HYAFF11/R-Cem-based composite scaffolds by SEM analysis at 
different magnification: A) 100X, B) 150X, C)1000X 
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A more accurate investigation of scaffold morphology by FE-SEM allowed 
investigation of the distribution of different polymeric and ceramic phases into the 
scaffold matrix as a function of the chemical and physical properties highlighting the 
presence of the HYAFF11  hydrophilic phases (dark gray) embedded in the PCL 
hydrophobic matrix (light gray).  
 
Fig. 4.8: Morphology of PCL/HYAFF11®-based composite scaffolds by FE-SEM analyses. 
Detection of hydrophilic HYAFF11® (dark gray) patches onto the hydrophobic PCL (light gray) 
 
For the fibre reinforced samples a more ordered structural organization is observed with 
PLLA fibres were well integrated into the PCL matrix without any significant alteration 
of pore morphology. PHF samples show a bimodal porosity characterized by two 
different pore size: a microporosity with small pore sizes ranging 1–10 ?m and a macro-
porosity with 100–400 ?m pore size have been distinguished. Marked differences in 
micro - and macropore morphology are also apparent on comparing scaffolds with and 
without fibres. More specifically, a reduction in macroporosity as well as concomitant 
increase in microporosity have been revealed in the case of PHF, ascribable to the 
different amount of templating agent and polymer solution concentration used during 
the preparation.  
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Fig. 4.9: SEM analysis of fibre-reinforced composite scaffolds at different magnification: (A) pore 
morphology (120X) and (B) organization of PLLA fibres inside porous PCL matrix(420X) 
  
As support of the qualitative investigation on scaffold morphology, a quantitative 
evaluation of porosity, pore size distribution and specific surface area was measured by 
?-tomographic analysis. First, the stack of X-ray images radiographs was rendered as 
planar 2-D slices  in order to describe the scaffold architecture. Afterwards, the volume 
rendering was carried out to assess basic porosity parameters in the three-dimensional 
space. Figure A and B depicts a ?-CT reconstruction  of two different  structures 
respectively PHRS and PHF. 
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Fig. 4.10: differences in pore size distribution between reinforced PCL composite scaffolds :A) 
PHF, B) PHRS and C) PCL/HYAFF11 unreinforced structure. 
 
Micro CT images confirm the preliminary indications obtained by SEM regarding pore 
size and spatial distribution of pores. It is apparent that the prepared scaffolds is highly 
porous with an irregular interconnected porosity. The ?CT data can also be used to 
quantify relevant scaffold parameters. 
 Porosity (%) Specific surface area (mm-1) Average pore size (?m) 
PHS 79,4 ± 1,4 52,59 ± 1.94 132 ± 3 
PHRS 78,5 ± 0,5 44.97 ± 0,72 140 ± 3 
PHF 69,2 ± 0,8 29.09 ± 4.04 219 ± 3 
Tab. 4.1: comparison between structural parameters of PHS, PHRS and PHF samples. All 
structure show high porosity degree and high value of specific surface area. 
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In Table 1, a summary of porosity features for the different scaffolds is reported. 
Porosity degrees ranged from 75.5 to 87.8%, pore sizes from 170.5 to 230.4 ?m and 
high value of specific surface area. This result assure that scaffold provide high surface 
areas for cells adhesion and proliferation and fully interconnected porosity that allows 
vascularisation, tissue ingrowth and adequate nutrient transport.  
Pore size distribution maps highlight structural differences between the PHRS and PHF 
samples. Fibre reinforced samples PHF show a more homogeneously distributed 
macroporosity with a peak around 201-245?m. Moreover in the PHF structure is 
possible to find also a pores with dimension around 700-800?m. This is ascribable to 
the different dimension of templating agent used for this typology of structures. 
 
4.3.2 Thermal analysis 
Dsc thermograms of all the scaffold typologies are shown in figure. For all materials an 
endothermic peak was observed, whose enthalpy change was found to depend on PCL 
content and attributed to the melting of PCL. The melting temperature decreased to a 
small extent for the composite scaffolds, from 66.66 ºC for pure PCL to 63.70 ºC for the 
composite. PLLA composite scaffold shows two endhtoermic peak: the first one due to 
the melting of PCL and a smaller second one due to the melting of the PLLA  fibres at 
160 °C. 
 
Fig. 4.12: DSC thermograms of PCL composites scaffolds 
 
The value of melting temperatures as well as enthalpies are summarized in table  
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Tab. 4.2:DSC results for all the four typologies of scaffolds 
 
Thermogravimetric curves (TGA) of  PCL and PCL composite are given in Figure . 
Thermal decomposition of each sample takes place in a programmed temperature range 
of  30-700ºC. In the case of PCL we have only one weight loss between 350 and 425 ºC 
due to the polymer degradation. For the PHS material we have a first weight loss 
between 60 and 100 ºC due to the heat of vaporization of water retained by the 
Hydrogel. The second weight loss between 200 and 300 ºC corresponds to the 
degradation of the Hyaff 11, finally the third weight loss between 350 and 400 ºC due to 
the PCL degradation. The same situation was also observed for the PHF scaffolds with 
the only difference that a further weight loss was registered between 250 and 300 °C 
due to the PLLA fibres degradation. For the calcium phosphate composite it is possible 
to recognize a certain percentage of material that doesn’t degrades over 700 ºC. This 
mass retain over 700 ºC is due to the presence of R-Cem that is the mineral phase and 
doesn’t degrade until 1000 ºC.  
 
Fig. 4.11: Thermogravimetric curves of PCL composite scaffolds with relatives differences in 
derivates signal. 
Sample ?Hf  (PCL) 
 (J/g) 
?Hf  (PLLA) 
 (J/g) 
Tf (PLLA) Tf (PLLA) 
PS 105.50 - 66.66 - 
PHS 80.52 - 64.04 - 
PHRS 70.78 - 64.41 - 
PHF 60.39 7.91 63.70 160.26 
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Below it is reported the percentage weight loss of pure PCL and composite PCL 
scaffold at different temperature. 
Temperature  range (ºC) PS (%) PHS (%) PHRS (%) PHF (%) 
30-100 0 1.7 2.5 1.2 
200-250 0 13.1 12.9 8,6 
250-330 0 0 0 14,7 
330-450 98.9 83.3 73.5 60 
Residue over 700 0.7 1 10 2,6 
Tab. 4.3: Weight losses and decomposition temperatures in a programmed temperature range 
between 30 and 700°C 
 
Looking at the value in the table a possible  correlation between the weight loss and the 
initial composition of the structures can be drawn.  
 
4.3.3 Mechanical properties 
In order to observe the mechanical properties of the scaffolds, a compressive load was 
applied to each sample of dimensions 10mm height and 5 mm diameter. . Constant 
speed of 1mm/min were exerted until the final failure or densification occurred. Pure 
PCL scaffold was also tested for the purpose of comparison. 
The static compression tests enabled to obtain the stress/strain curve of composite 
scaffolds. Firstly, it describes the mechanical behaviour of porous systems under static 
conditions: it shows a linear elasticity at low stresses followed by a long collapse 
plateau truncated by a regime of densification in which the stress rises steeply.  
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Fig. 4.12: stress strain curve of PHF and PHRS composite structure. PHF samples show better 
mechanical properties if compared with the calcium phosphate composite structure. 
 
Unreinforced PS sample shows the lowest mechanical properties in the case of the 
elastic modulus is equal to  0.07 MPa. The addition of 13% vol hydroxyapatite particles 
to PCL matrix causes a small increase of elastic modulus (from 0.13 to 0.17 Mpa). 
Despite the addition of the R-Cem elastic modulus of the two samples remain 
comparable due to the high degree of porosity. For the fibre reinforced sample the 
elastic modulus rise up to one order reaching a value of 2.41 MPa. This increase is due 
either to the fibre reinforcement than to the lower porosity degree related to a more 
compact structure.  
Tipo PCL / NaCl Modulo elastico (Mpa) 
PHRS2 5 / 95 0.170 ± 0.025 
PHS2 5 / 95 0.076 ± 0.027 
PHF2 2/ 8 2.41 ± 0.55 
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Fig. 4.13: evaluation of  the elastic modulus as function of the type of reinforcement. 
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The evaluation of static curve is preparatory to the dynamic mechanical analyses. Indeed, the 
definition of the elastic range allowed to establish the  average load and amplitude to apply for 
the cyclic stimulation. 
 
Fig. 4.14: scheme of different steps to analyze Dynamic mechanical properties: A) evaluation of 
linear region, B) detection of mean load value related to the elastic deformation of the sample, C) 
Load history imposed to the composite structure. 
 
Dynamic tests confirm the result obtained by static compressive test. Fibres reinforced 
samples is much stiffer with a young modulus of 2.41 MPa, than PHRS as measured by 
static compressive test.  The dynamic behaviour was described by the following 
viscoelastic moduli:  
• The storage modulus: E’ = (σ0/ε0)cosδ 
• The loss modulus: E’’ = (σ0/ε0)sinδ  
In the proposed tests, the cyclic stimulation was originated by a sinusoidal stress with 
dynamic amplitude that has been evaluated from the elastic region of the stress-strain 
curve.  All tests have been performed in water at body temperature in order to simulate 
the native microenvironment of bone tissue. 
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Fig. 4.15: Storage modulus, loss factor and damping of composite PCL based scaffolds in function 
of frequency. 
 
Moreover the test highlights the viscoelastic behaviour of the samples showing that E’ 
increases with frequency. Otherwise loss modulus E’’ is not significantly affected as 
frequency varies. The evolution of elastic moduli was evaluated varying the frequency 
from 0.1 to 10 Hz. This enabled to estimate a comparative analysis of the storage 
modulus “E’” (elastic component) equivalent to the energy stored through deformation 
and the loss modulus “E’’” equivalent to the energy dissipated through the cycled 
stimulation. Finally, the estimation of E’/E’’ ratio (tanδ) allowed to directly visualize 
the relative contribution of elastic and viscous component at different frequencies, 
which participate to the viscoelastic behaviour of the scaffold. This study is a 
preliminary way to evaluate the material capability of stress transfer to cells in order to 
investigate the effect of mechanical stimulation on cell activities. Moreover from the 
dynamic characterisation it’s possible to have indication about the mechanical  
behaviour of the sample for the in vivo test.  
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4.3.4 In vivo test 
After 12 weeks implants were removed and prepared for the histological evaluation. 
Evaluation of the osseous implantation by light microscopy showed the biocompatible 
behaviour of all the three types of implants that did not evoke tissue inflammation or 
foreign body reaction in the surrounding bony tissue at the examined experimental 
times. As expected, the formation of new bone in the scaffold alone remained restricted 
to the edge of the defects and the largest part of the centre of the defect remained free of 
bone up to 12 weeks. 
 
 
Fig. 4.16: Histological evaluation of PHF structure alone  through Acid Fuchsin and Fast Green 
staining. (S: scaffold; C: cortical bone; NB: newly formed bone) . 
 
The scaffold was still present into the bone gap after 12 weeks and there was totally 
absence of fibrous tissue all around it. Newly formed trabecular bone is present all 
around the impants. PHF scaffold with BMSCs treated with platelet rich plasma (PRP) 
showed a better response with more newly formed trabecular bone observed at the 
bone-scaffold interface and on the external surface of bone and scaffold.  
 
 
Fig. 4.17: Histological evaluation of PHF + BMSCs + PRP structure  through Acid Fuchsin and 
Fast Green staining at different magnification: a)1.25X, b) 4X . (S: scaffold; C: cortical bone; NB: 
newly formed bone) 
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Higher amount of newly formed bone trabeculae  is evident in the case of BMP7 loaded 
cell free PHF scaffold as is possible to see from its histology  
 
Fig. 4.18: Histological evaluation of PHF + BMP7 structure  through Acid Fuchsin and Fast Green 
staining at different magnification : a) 1.25X, b) 4X (S: scaffold; C: cortical bone; NB: newly 
formed bone) 
 
The regrown bone of this type of scaffold appear to be more similar to normal bone than 
that of the other two typologies of structure.   
 
 
Fig. 4.19: fluorescence microscopy of  a PHF/BMP7 section coloured with : a) Alizarin Red and b) 
Xylenol Orange 
 
Moreover PHF/BMP7 scaffolds showed a high xylenol orange and alizarin red activity 
indicating an intense bone formation after 12 weeks confirming the osteogenic activity.  
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4.4 Conclusions 
The current challenge in scaffold design is to fabricate reproducible bioactive and 
bioresorbable 3D scaffolds with tailored porosity and pore morphology, capable of 
maintaining structure integrity for a predictable period, even under load-bearing 
conditions. Here, three different typologies of composite scaffolds have been proposed 
by the integration into the PCL matrix of different material phases: HYAFF11, as a 
hydrophilic cue; R-cem (particles) as reinforcement systems by using conventional 
phase inversion/salt leaching technique (i.e., PHRS); or incorporation of PLA long 
fibers by filament winding technique (i.e., PHF). The morphological features, the 
degradation and mechanical properties and the cellular response of the three different 
typologies were investigated. All scaffold prototypes showed a bimodal porosity, 
characterized by macropores arising from salt crystal dissolution, and micropores 
formed by the controlled removal of solvent via non-solvent exchange. The 
investigation of morphology by Xray micro-computed tomography (micro-CT,), 
allowed a quantitative assessment of scaffold porosity features (pore size, structural 
porosity and degree of anisotropy) as summarized in Table 1. Porosity and pore sizes of 
PHS scaffolds are firstly affected by the response of the HYAFF11  phases to the water 
retention, leading to a slight underestimation of pore sizes (around 170 ?m) due to 
swelling of the hydrogel through absorption of environmental moisture. 
In the case of PHF scaffolds incorporating PLA fibres, a drastic decay of the porosity 
degree, from 81.7% to 63.1%, was observed, cause a smaller weight amount of sodium 
chloride crystals was used in order to reduce the solution viscosity, and thus optimize 
the fiber/matrix adhesion, during the winding process. Pores ranges in size from 60 to 
400 ?m, with an average pore size of about 200 ?m, the specific surface area varies 
between 32 mm2/mm3 for the PHF scaffolds to the 63 mm2/mm3 of the PHRS. TGA 
analysis evaluate the effective weight percentage of every single components in the 
composite scaffold. For pure PCL samples, the TGA curve is characterized by a drastic 
lost mass between 330 and 450 °C. For the composite sample PHRS and PHS it is 
interesting to notice a first weight loss between 30 and 100 °C probably due to 
evaporation of the water retained in the HYAFF phase. Moreover PHRS sample show a 
residue over 700 °C that confirm the presence of the ceramic phase (R-Cem) inside the 
matrix. The incorporating of Calcium phosphate crystals into the PCL polymer matrix 
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slightly improve the mechanical leaving unaltered the pore morphology. Fibres 
reinforced samples shows the best mechanical properties with an increase of one order 
of magnitude in elastic modulus if compared with non reinforced PCL scaffolds. 
Dynamic analysis confirm the results obtained from the static characterization with the 
PHF sample that shows the highest elastic modulus and highlights the viscoelastic 
behaviour of the samples showing that E’ increase with the frequency while E’’ seems 
to be not really affected as frequencies varies. Finally an in vivo study has been 
performed in collaboration with the orthopaedic institute Rizzoli in Boulogne. The test 
has been performed on the fibre reinforced scaffold in three different configuration: 
PHF alone, PHF with BMSCs and Platelet rich plasma (PRP), PHF with BMP7. After 
12 weeks all the three typologies of scaffold did not evoke tissue inflammation or 
foreign body reaction in the surrounding bony tissue. Histologies show that PHF 
scaffolds, treated with BMP7,  has the highest newly formed bone trabeculae.  
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CHAPTER 5 
Design of porous three dimensional PDLLA scaffolds 
using stereolithography 
 
5.1 Introduction 
Scaffold design parameters including porosity, pore size, interconnectivity, and 
mechanical properties have a significant influence on cell seeding and 
differentiationv[1][2]. This chapter evaluates the ability of Stereolithography (SLA) to 
be used to tailor scaffolds design to optimize these parameters.  
Tissue engineering scaffold prepared by rapid prototyping techniques have several 
advantages when compared to those fabricated by conventional techniques that often 
result in inhomogeneous scaffolds with broad pores size distribution, poor pore 
interconnectivity and inferior mechanical properties[3]. Rapid prototyping allows the 
preparation of scaffolds with optimal properties regarding pore, structure and 
connectivity, geometry, mechanical properties , cell-seeding efficiency, and transport of 
nutrients and metabolites [4]. Laser micro-stereolithography (µSL) has become an 
accepted rapid prototyping technique that allows 3D microfabrication of solid models 
from images created by computer-aided design (CAD) programs [5]. Its working 
principle is based on spatially controlled solidification of a liquid photo-polymerisable 
resin[6].  The limited number of resin that are commercially available for processing by 
stereolithography has often been considered the main limitation of the technique. The 
resin should be a liquid that rapidly solidifies upon illumination with light. Most of the 
available resin are based on low-molecular weight, multi functional monomers, and 
highly crosslinked network are formed[7]. These materials are predominantly glassy, 
rigid and brittle. Only few resin have been described that allow the preparation of 
elastomeric objects by stereolithography[8]. These resin formulations include 
macromers with low glass transition temperatures and relatively high molecular weight 
often in combination with diluents such as N-methylpyrollidone (NMP) or water to 
reduce the viscosity of the resin[9]. Most materials used for stereolithography are 
conventional epoxy resins, thermoplastic elastomers, and poly(ethylene-glycol) (PEG)-
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based hydrogels. They have limited application in bone tissue engineering because of 
the lack of biodegradability or sufficient mechanical strength [10]. The only 
biodegradable macromers that have been applied are based on trimethylene carbonate 
and ε-caprolactone oligomers, or on poly(propylene-fumarate) [11][12]. The latter 
requires a reactive diluent such as diethyl fumarate to obtain an appropriate reaction rate 
and viscosity of the resin [13]. 
For tissue engineering of hard tissue such as bone, strong and rigid biodegradable 
materials are required. Polylactide is such a material , and it has a long track record of 
successful application in the clinic and for the preparation of tissue engineering 
scaffolds. It is strong and stiff and degrades to yield lactic acid. The polymer has been 
extensively applied in porous scaffolds suitable for bone tissue engineering [14]. A 
degradable photo-polymerisable system can be obtained by chain-crosslinking 
hydrolysable oligomers with reactive end groups [15]. Poly(D,L-lactide) (PDLLA) 
functionalised with methacrylate groups can be crosslinked to form rigid polymer 
networks [16]. They have been applied in resorbable bone fixation devices clinically 
and for use in bone tissue engineering. Beside the properties of the material also the 
pore architecture of a scaffold is of great influence on its functionality. The architecture 
influences mechanical properties, cell adhesion and proliferation, transport phenomena 
and degradation behaviour. Using stereolithography techniques structural parameters 
such as porosity and pore size, and even gradients thereof, can be freely varied.  In this 
chapter, we will show how to design biodegradable porous structure with refined 
architectures and prepare these by stereolithography at high resolution.  
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5.2 Materials and Methods 
5.2.1 Materials 
D,L-Lactide was obtained fromPurac Biochem, The Netherlands. Hexanediol, 
stannous octoate, methacrylic anhydride (MAAH), tocopherol, dibenzopyrazine 
were purchased from Sigma–Aldrich, USA and used without further purification. 
Triethyl amine (TEA) (Fluka, Switzerland), ethyl lactate (Merck, Germany), and 
technical grade isopropanol and acetone (Biosolve, The Netherlands) were used as 
received. Orasol Orange G was gift from Ciba Specialty Chemicals, Switzerland. 
Lucirin TPO-L (ethyl-2,4,6-trimethylbenzoylphenylphosphinate) was a gift from 
BASF, Germany. Analytical grade dichloromethane (Biosolve, The Netherlands) 
was distilled from Calcium Hydride (Acros Organics, Belgium).  
5.2.2 Macromers synthesis 
Oligomers are obtained by a ring-opening polymerization of the D,L-Lactide for 
40h at 130ºC under an argon atmosphere, using Stannous Octoate Sn(Oct)2 as 
catalyst. 1,6 Hexanediol is used as initiator to prepare 2-armed oligomers.  
 
 
Fig. 5.1:Ring-opening polymerization reaction of (D,L-lactide) using difunctional alcohol ad 
initiator and Sn(Oct)2 as catalyst 
 
The molecular weight and arm lengths are varied adjusting the monomer to initiator 
ratio. Proton-nuclear magnetic resonance spectroscopy (1H NMR , CdCl3, Varian 
300 MHz)  are used to determine lactide monomer conversion and oligomers 
molecular weight.  
Oligomers are functionalized by reacting the hydroxyl groups with Methacrylic 
anhydride (MAAH) under argon atmosphere. The formed methacrylic acid is 
scavenged with Trietilammine (TEA). An excess of MAAH and TEA per hydroxyl 
group is used. 
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Fig. 5.2: functionalization of poly(D,L-Lactide) with Methacrylic anhydride in presence of 
tryethilamine 
 
Macromer solution is filtered and precipitated into cold isopropanol, the isolated 
macromers are then washed with water and freeze dried. 1H NMR is used to 
determine degree of functionalization of the macromers.  
 
5.2.3 PDLLA resin for stereolithography 
To be able to apply PDLLA macromers in stereolithography, the macromer must be 
in the liquid state [17]. Reactive diluents such as methyl methacrylate, butane-
dimethacrylate and N-vinyl-2-pyrollidone have been used in regular photo-
polymerisation reactions [10][18] and in stereolithography [19][20]. 
To formulate liquid polymerisable poly(D,L)lactide resin, three different solvent 
were tested in different amount: (a) Ethyl Lactate, (b) Propylene carbonate, N-
methyl-2-pyrollydone. Macromers were diluted with varying amount of solvent, and 
their viscosities have been determined at 25°C using a Brookfield DV-E rotating 
spindle viscometer, equipped with a small sample adapter. The shear rate was varied 
between 0.3 and 6.0 r.p.m. to prevent crosslinking 0.2 wt% of hydroquinone was 
added to the liquid. To obtain networks the resin containing 2.0 wt% of Lucirin TPO 
as a biocompatible UV photo-initiator, were irradiated with 365 nm UV-light for 15 
min (Ultralum rosslinkng cabinet, intensity 3-4mW/cm2). Teflon mould, covered 
with fluorinate ethylene-propylene (FEP) films to avoid oxygen inhibition, were 
employed to prepare film measuring 20x20x1.5 mm3.  
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5.2.4 Stereolithography 
To fabricate PDLLA structure with stereolitoghraphy poly(D,L-lactide) 
dimethilmethacrylate macromers have been solved in N-methyl-2-pyrrolidone 
(NMP) 45%wt. To prevent premature crosslinking 0,2% Tocopherol (Vitamine E) 
will be added to the solution. To obtain the network the resin contain 4,0% wt of 
Lucirin as a biocompatible UV  photo initiator. The final resin composition will be 
68% macromer, 31% Propylene carbonate (or NMP), 2.7% Lucirin photo initiator, 
0,13% Tocopherol as antioxidant agent and 0,1% of Orange orasol dye. This resin 
will be used to prepare designed porous structures with a commercial 
stereolithography setup (Envisiontec Perfactory). Tensile test specimen (ISO 37-2), 
film measuring 20x20x1.5 mm3 and scaffold with various 3D architecture were 
designed using Rhioceros 3D (McNeel Europe) and K3dSurf v 0.6.2(obtained from 
http://k3dsurf.sourceforge.net) computer software After building, the scaffold have 
been extracted with a mixture of isopropanol/acetone (3/1) and dried at 90°C for 2d. 
 
5.2.5 Design of porous structures 
To build porous tissue engineering scaffolds in a stereolithography setup a mixture 
of  3.0 kDa PDLLA dymethacrilate, 45 wt% (relative to the amount of macromers) 
NMP, 4 wt% of Lucirin photo-initiator, 0.2wt% of Tocopherol as antioxidant, 
0.15wt% of Orange Orasol dye. The size of the smallest features that can be built 
are determinated by the size of the pixels (32x32 µm2 in the x and y direction), the 
layer thickness (25µm).  K3DSurf v0.6.2 software  was used to generate CAD-files 
that describes the surfaces of Schwartz (S), Diamand (D) Gyroid (G) and Double 
Gyroid (DG) architectures. Their surfaces are defined by trigonometric implicit 
functions, where the spatial variables are symmetrically ordered within the 
trigonometric terms. The functions are triply periodic and are uniquely defined by 
its unit cell. They closely approximate the minimale surface of Schwarz and Schoen 
[21]. The following trigonometric functions were used with boundary condition 
x,y=[-10,10] and z=[-20,20]: 
• S: cos(x) + cos(y) + cos(z) = 0.6 
• D: sin(x) *sin(y) *sin(z) +sin(x) * cos(y) * cos(z) +cos(x) * sin(y) * cos(z) + 
cos(x) * cos(y) * sin(z) = 0.4 
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• G: cos(x) * sin(y) + cos(y) * sin(z) + cos(z)* sin(x) = 0.6 
 
To obtain porous structure with porosities of approximately 70% offset values of -
0.6 for the Scwartz, -0.4 for the diamond and -0.6 for the gyroid are required. 
Rhinoceros software was used to scale the CAD files of all three architectures to the 
desire dimension. Envisontec Perfactory RP 2.0 software  was used to slice the 3D 
CAD-files. The stack of bitmaps generated, is the input for the layer-by-layer 
building process. 
 
5.2.6 Analysis of built structures 
Structural analysis was performed by micro-computed tomography (µCT) using a 
Sky Scan 1072 at 10 µm resolution. Scanning was done at an X-ray tube voltage of 
52 kV, a current of 152 µA with a rotation angle of 180 °C and an exposure time of 
1900 ms. Scanning electron microscopy (SEM)(Philips XL30 operated at 10 
(kV)was used to visualize the built structures.  
 
5.2.7 hMSCs culturing 
Bone marrow-derived hMSCs (Clonetics, Italy), at passage 5, were cultured in a-
modified Eagle’s medium (a-MEM) (BioWittaker, Belgium) containing 10 vol.% 
foetal bovine serum (FBS), 100 U/ml penicillin and 0.1 mg/ml streptomycin 
(HyClone, UK), in a humidified atmosphere containing 5% CO2 at 37 °C. 
 
5.2.8 Scaffold cell seeding 
Scaffolds for cell culture experiments, with a Double Gyroid architecture , were 
prepared for cell seeding by first soaking in 70% ethanol (1 h) and then 1% 
antibiotic/antimycotic in phosphate-buffered saline (PBS) (2 h), and pre-wetting in 
medium (2 h). 4 x 105 cells, resuspended in 50 ?l of medium, were statically seeded 
onto the scaffold. After seeding the scaffolds were placed in 24-well culture plates 
(1 scaffold per well) and, incubated for 2 h in a humidified atmosphere (37 °C, 5% 
CO2). 
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5.2.9 Alamar blue assay 
Cell viability and proliferation were evaluated using the Alamar blue assay. This is 
based on a redox reaction that occurs in the mitochondria of the cells. The coloured 
product is transported out of the cell and can be measured spectrophotometrically. 
The cell–scaffold constructs were removed from the culture plates on days 1, 7, 14, 
21 and 28, rinsed with PBS (Sigma–Aldrich, Italy) and placed in 24-well culture 
plates. For each construct 1 ml of Dulbecco’s modified Eagle’s medium (DMEM) 
without Phenol red (HyClone, UK) containing 10 vol.% Alamar blue (AbD Serotec 
Ltd., UK) was added, followed by incubation in a 5% CO2 atmosphere for 4 h at 
37°C. An aliquot of 200 ?l of the solution was subsequently removed from the wells 
and transferred to a 96-well plate. The optical density was immediately measured 
with a Sunrise spectrophotometer (Tecan, Männedorf, Switzerland) at wavelengths 
of 540 and 600 nm. The number of viable cells correlates with the level of dye 
reduction and is expressed as percentage of Alamar blue reduction (%AB 
reduction), according to the manufacturer’s protocol. Moreover, the number of 
viable cells on the scaffolds was determined by comparing the absorbance at 
different culture times with a calibration curve obtained by correlating known cell 
numbers in the 24-well culture plates with the corresponding absorbance values. 
Each experiment was performed three times in triplicate. 
 
5.2.10 SEM analysis 
SEM analysis was performed to evaluate cell morphology and colonization 4 weeks 
after seeding. The cell–scaffold constructs were extracted from the wells, the 
medium was removed and the specimens were fixed in 2.5% glutaraldehyde in 0.1 
M sodium cacodylate buffer, pH 7.4 for 1 h at room temperature. This was followed 
by rinsing twice with PBS and dehydration in a graded series of ethanol (50, 60, 70, 
80, 90 and 100 vol.%) for 5 min each. Finally, the specimens were air dried and 
sputter coated with gold. The cell morphology on the scaffold was observed with a 
Leica Cambridge (Stereoscan S440) scanning electron microscope. 
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5.2.11 CLSM 
For the CLSM analysis the construct were extracted at 21 days  after seeding, fixed 
with 4% parapholmadeyde for 20 min at RT, rinsed twice with PBS buffer and 
incubated with PBS-BSA 0,5% to block nonspecific binding. Actin microfilament 
were stained with phaloidin tetramethylrhodamine B isothiocyanate (Sigma-Aldrich, 
Italy). Phalloidin was diluted in PBS-BSA 0,5% and incubated for 30 min at RT. 
Samples were then observed by an inverted fluorescence microscope (IX50, 
Olympus, Italy), using 4X, 10X and 20X objectives.  
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5.3 Results and Discussions 
5.3.1 Macromer synthesis 
The monomer conversion and the arm length of the synthesised lactide oligomers 
was derived from 1H-NMR spectra. The lactide conversion was determined from the 
ratio of the peak areas corresponding to the monomer -CHCOO- protons ( 5.05 
ppm) [a’] and the oligomer -CHCOO- protons (5.15 ppm) [a]. Conversion reached 
were above 90%.  
 
Fig. 5.3: 1H NMR Spectra of lactide oligomer 
 
Looking at the peak of the spectra and matching the oligomer -CHCOO- proton 
(5.15 ppm) [a] with the hexandiol -CH2O- proton (4.1 ppm) [c] , it is possible to 
estimate molecular weight of oligomers in this way: 
nxaArea
cArea
1
2
][
4
][
=  
Where Area[c] = 0.09;  
Area[a] = 1;    Xn = 22  Where xn is number of monomer for chains. 
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Fig. 5.4: 1H NMR Spectra of functionalized macromers 
 
The degree of functionalization was determined from the peak areas corresponding 
to the methacrylate protons (5.65 and 6.1 ppm) [e] and [e’] and the hexanediol -
CH2O- protons (4.1 ppm) [c]. degree of functionalization of 100% was a guaranteed 
from the absence of end groups peak at 2.75 ppm.  
 
5.3.2 Viscosity test 
Macromers were dissolved in three different unreactive solvent: Propylene 
carbonate (PC), ethyl lactate (EL) and N-methyl-2-pyrollidone (NMP) and their 
viscosity were determined at 25 °C. The viscosity of all formulation  were strongly 
dependent on the amount and the type of solvent used. Our goal was to reach the 
lower viscosity with the lowest amount of solvent. As is possible to notice in Figure 
11 the best solvent to use was NMP. 
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Fig. 5.5: the resin viscosity of PDLLA macromers dilueted with different amount of solvent. 
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 Viscosity (Pa·s) 
Amount of solvent 
(wt%) 
Propylene carbonate Ethyl lactate N-Methyl-2-Pyrollidone 
35 127,5 21,89 23,48 
40 47,05 13,22 11,14 
45 18,05 10,54 6,36 
50 9,12 5,65 4,22 
Tab. 5.1: PDLLA resin viscosity strongly depend from the amount and type of solvent used to 
diluite the macromers. 
 
Once that it was found the best solvent it is necessary to find the right amount to use 
for stereolithography application. So PDLLA macromers were dissolved in different 
amount of NMP and their viscosity were determined at 25°C varying the shear rates 
between 0.3 and 6.0 r.p.m. To obtain resin with a viscosity comprised between 5 and 
10 Pa·s an amount of 45 wt%  of NMP was required.  
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Fig. 5.6: The resin viscosity of PDLLA macromer as a function of the solvent diluent 
concentration. 
 
5.3.3 Stereolithography 
Similar to a conventional stereolithography process, the DMD (Digital micro 
Device)SL created 3D microstructures in a layer-by-layer fashion. The shapes of the 
constructed layers were determined by slicing the desired 3D scaffold design into a 
series of evenly spaced planes. Patterns of each layer were drawn in a series of 
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PowerPoint slides, which were then executed on the DMD chip to generate a 
dynamic mask . The illuminated area was solidified simultaneously under one 
exposure, while the dark regions remained in the liquid phase. After one layer was 
patterned, the substrate was lowered and the as-patterned layer was then covered by 
fresh macromer solution. Microstructures with complex geometries were created by 
sequentially polymerizing the layers [5]. The thickness of a solidified layer (cure 
depth, Cd in µm) is controlled by the light irradiation dose E(mJ/cm2). A plot of the 
cure depth versus the irradiation dose is termed Working curve and can be described 
by: 




=
c
pd E
EDC ln  
 
This equation is an adapted form of the Beer-Lambert equation, which describer the 
exponential decay of intensity of light as it passes through a medium in which it is 
absorbed. The depth at which the resin is cured to the gel point (Cd) increases 
logarithmically with time, and thus with the applied irradiation dose (E). for a 
specific stereolithography setup, a resin can be characterized by a critical energy 
Ec(mJ/cm2) and a penetration depth Dp. As the applied irradiation dose (E) exceeds 
the critical energy Ec, a solidified layer forms from the resin surface. The 
penetration of light into the resin is directly related to the extinction coefficient in 
the Beer-Lambert equation, and is characterized by Dp. to achieve good attachment 
between layers, the conversion of the macromer at the interface of the layers should 
be slightly higher than the gel point. In our experiments, a light irradiation dose that 
is between 30 to 35% higher than that required to realize the step height of the 
building platform, was found to be well suited. This overcure will affect inevitably 
pore size and geometry when building porous structures. A high value of the 
extinction coefficient of the resin correspond to a small Dp, and will allow minimal 
overcure and most accurate control of the building process.  
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Fig 5.7. Stereolihography working curves  of 1.5 kDa PDLLA macromer-based resins 
containing 0,2 wt% of Orange Orasol (Purple dot) and containing no dye (blue dot) 
 
Figure 6 shows working curves for resin prepared from 1.5 kDa PDLLA macromer, 
which further contain 31% of NMP and 2,7% of Lucirin photo-initiator. From the 
slope of the working curve , it can be seen that the penetration depth of the resin 
decrease from 800µm to 100 µm upon the addition of 0.2 % of Orasol Orange G 
dye.   
 
5.3.4 Design of porous structure 
Scaffold design parameters such as porosity, pore size , interconnectivity and 
mechanical stiffness, have been shown to influence the cell attachment and 
differentiation on scaffold both in vitro and in vivo [22][23]. 
The demonstrated importance of these scaffold parameters dictates that an optimal 
bone tissue engineering scaffold must be achieved for the stimulation of desired 
signal expression and the induction of osteogenic differentiation of the recruited cell 
population. Along with the combination of other chemical and biological factors 
such as the administration of growth factor proteins, the repeated construction of 
precisely controlled architectures with the optimal design parameters is necessary to 
achieve an optimal bone tissue engineering scaffold. SLA technique enables 
scaffolds to be reproduced with controlled porosity, pore size, interconnectivity, and 
mechanical properties, all of which greatly influence cell attachment and 
differentiation.  Using the SLA, three different sophisticated structure were built: a 
Scwartz, a Diamond and Double Gyroid architecture.  
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Fig. 5.8: Visualization of different porous architectures. Columns: (1) CAD- design of the 
repeating unit cells, (2) CAD-design of final structure. 
 
Computer models can be generated repeating the respective unit cells in the space.  
Structure measuring 5x5x10 mm3 were then built by stereolithography using a resin 
based on PDLLA macromers and a non-reactive diluents using Lucirin TPO as 
photo initiator ad hydroquinone to prevent crosslinking. Upon removal of solvent 
the structure shrink by 45%. This shrinkage is homogeneous and reproducible, and 
could be compensated  by adjusting  the dimension of the design.  
 
5.3.5 Double Gyroid architectures 
Starting from the Gyroid architectures [9] it has been developed a new architecture 
that we have called Double Gyroid. The idea has been to consider the absolute value 
of the Gyroid equation, in this way it has been realized an architecture in which we 
had two interpenetrated Gyroid structures. 
 
• 15.1))sin()cos()sin()cos()sin()(cos( −⋅+⋅+⋅ xzzyyxabs  
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 Unit cell       Final structure 
Fig. 5.9: Visualization of the unit cell and final structure of the Double Gyroid architecture 
 
Using the following  boundary conditions: 
• ( ) ( ) pipi 55 222 ≤≤+ zyx &  
 
Fig. 5.10: CAD- visualization of the Double Gyroid architecture after the application of 
boundary conditions. 
  
Structure built according with to this mathematically defined architecture for tissue 
engineering, have a large specific surface and high pore interconnectivity. These 
characteristics make it an excellent architecture for tissue engineering, as it enables 
cells-seeding at high density, and allows homogeneus distribution of cells ad flow of 
nutrient throughout the scaffold. To obtain porosity of approximately 78%, offset 
value of 1.15 is required. Rhinoceros software was used to scale the CAD-files to 
the desired dimensions. Envisiontec Perfactory RP 2.0 software was used to slice 
the 3D CAD-files. 
 
5.3.6 Analysis of porous structure 
To asses the accuracy of the stereolithography technique Scanning electron 
microscopy and µCT analysis was performed over the three different architecture. 
The graphical data obtained with µCT scanning was compared with the CAD data 
enabling quantifiable comparison. Under the applied experimental condition, 
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building times were approximately 8 h.  Figure 17 shows SEM images respectively 
of the : (A) Schwartz architecture, (B) Diamond architecture and (C) Double Gyroid 
architecture.  
 
Fig. 5.11: SEM images of  porous structures with different architectures built by 
stereolithography: (A) Schwartz architecture, (B) Diamond architectures, (C) Double Gyroid 
architectures. 
 
The ability of a scaffold to enhance specific signal expression and support tissue 
formation is largely dependent on the pore size and porosity of the structure. 
Porosity refers to the overall percentage of void space within a solid, whereas pore 
size reflect the diameter of individual voids of the scaffold [24]. Porosity and pore 
size have significant ramification on the ability of tissue engineering scaffolds to 
support tissue regeneration for several reason. First, porosity and pore size have 
been show to affect cell differentiation through changes in signalling distances [25]. 
Pore size has been observed to influence also the vascularization , which is crucial 
to successful tissue formation. Rapid vascularisation is important for tissue growth 
in an implanted scaffold as cells on the interior portion of the scaffolds will not 
survive without a blood  nutrient supply. Interconnectivity between the pores is 
another important requirement of scaffold architecture. Scaffolds that feature a 
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highly interconnected architecture allow communication between  cells different 
areas within a scaffold and promote tissue ingrowth.  The built scaffold closely 
resembled the design and it can be seen that the pore network is homogeneous in 
size and fully interconnected. At higher magnification, the layer-by-layer nature of 
the construct is clearly visible (Fig. 18).  
 
Fig. 5.12: layer by layer structure of double gyrois architecture. 
 
It follows that the use of PDLLA dimethactrilate/NMP enables the preparation of 
biodegradable scaffolds with highly controlled architectures and suitable 
characteristics for cells culturing. Because the complexity of the network inside a 
scaffold pore inteconnectivity can be difficult to assess, but the use of micro-
computed tomography (µCT) allows for a more precise definition and better 
assessment of scaffold characteristic.  
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Fig. 5.13: visualization of µCT-scanning of the Double Gyroid structures. 
 
From the µCT data, the structural parameters of the built scaffold after removal of 
the diluent were determinated. The designed architectures is preserved and porosity 
is almost unaffected. Table 1 summarizes porosity and specific surface parameters 
evaluated from the µ-CT. 
 Porosity (%) Specific surface area 
(mm-1) 
Average pore 
size (mm) 
Architecture CAD Built CAD Built Built 
Schwartz 63.68 66.97±1,44 6.18 11.41±1,56 0,615±0,04 
Diamond 72.51 79.25±1.44 7.09 19,62±1,56 0,559±0,04 
Double Gyroid 78,47 78,16±1,54 10.02 13,89±0,68 0,745±0,02 
Tab. 5.2: Comparison of structural parameters of the designed structures and built porous 
structures as determined by µCT 
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High specific surface value and a porosity fully interconnected allow to think that 
Double gyroid is a good architecture for cell culturing.  
 
5.3.7 Biological characterization of seeded scaffold 
To demonstrate the suitability of these material for use in medical application such 
ad bone tissue engineering, hMSCs were seeded and cultured for 21 days on 
PDLLA Double Gyroid structure. Ferry et all. have already demonstrated that 
PDLLA network film obtained by stereolithography are excellent substrates for the 
culturing of cells [14]. Now it will be showed that Double Gyroid architecture is a 
suitable structure for cell seeding and and growing. The very open structure 
facilitates the penetration of water into our PDLLA scaffolds prepared by 
stereolithography. This allowed for intrusion of the cell suspension deep into the 
scaffolds and cells were distributed all throughout. So the cells seeding could be 
performed effortlessly by simply pipetting the cell suspension onto the scaffold.  
 
Fig. 5.14: Sem images of PDLLA Double Gyroid scaffold seeded with hMSCs after 21 days of 
culture. 
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The results demonstrate that the open architecture of the DB scaffold facilitates the 
infiltration of a cell suspension into the scaffold, despite its hydrophobic nature. In 
the static seeding there is a clear effect of scaffold permeability on final cell 
distribution. Cause the DG architecture is a very open structure, large cell cluster 
were found on the bottom of the scaffold. However due to the surface roughness 
many cell are retained inside the structure allowing their seeding and proliferation. 
Representative fluorescence and histological images of the cell-scaffold construct at 
day 21 after seeding are reported in figure 21. 
 
Fig. 5.15: Fluorescence microscope images of the cross sections of the cell-scaffold construct 
(objective 10X) 
 
It was possible to observe as that large cell cluster are present on the bottom and 
upper surface of the scaffold, as well as the progressive reduction of hMSCs 
colonization in the inner region of the porous structure, probably due to the high 
dimension of pore size. 
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Fig. 5.16: fluorescence microscope images at higher magnification (objective 20X) 
 
The values for Alamar blue assay provided a quantitative evaluation of the 
proliferation and the number of viable cells in the scaffold. As shown in Fig. 19 the 
proliferation of  hMSCs reached a plateau at 2 weeks and at the 3 weeks it starts to 
decrease. 
 
Fig. 5.17: Alamar blue assay for proliferation of hMSCs cultured on PDLLA Double gyroid 
scaffold at 48h, 7 days, 14 days and  21days. 
 
5.4 Conclusions 
In bone tissue engineering, a series of structural cues including pore size, porosity, 
interconnectivity, and stiffness have been found to be critical factors in activating 
osteogenic signal expression. Successful manipulation and fabrication of controlled 
architecture with optimal conditions of construction parameters may stimulate 
osteogenic signal expression as well as subsequent osteogenic differentiation. To this 
end, SLA is a promising and feasible strategy for fabrication of a designed architecture, 
which may show the best performance in vitro and in vivo. A resin based on poly(D,L- 
lactide) macromers and non-reactive diluent was developed and applied in 
stereolithography. Designed solid structures and porous scaffolds were prepared and 
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characterised from a morphologic, mechanical and biological point of view. 
Stereolithography fabrication methods can be used to accurately prepare tissue 
engineering scaffolds with design that can be modelled, allowing optimisation of the 
properties of the structures. Therefore, controlling the structural parameters may 
promise successful integration of the implants into the surgical sites and enhancement 
of boneregeneration. Mathematically defined porous structures with different 
architectures (Diamond, Schwartz, Double gyroid), were prepared using a liquid resin 
based on 2-armed PDLLA macromers and  N-methyl-2-pyrollidone. The characterized 
PDLLA structures show good mechanical properties with a open pore architecture fully 
interconnected. It was shown that the open, accessible architecture has improved cell 
seedability in fact hMSc readily adhered and proliferated well on this network.  
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CHAPTER 6 
Scaling the stereolithography process to develop new 
Poly(D,L-Lactide)/Nano-Hydroxyapatite bioactive 
composite scaffold. 
 
6.1 Introduction 
Natural bone is a nanocomposite consisting of mineral fraction including small apatite 
crystals and non-stoichiometric calcium phosphate and organic fraction which together 
confer mechanical resistance. It is a living tissue that constantly undergoes a coupled 
resorption–reparative process known as bone remodeling. The incorporation of a graft into 
bone will inevitably involve cellular and tissue response with regard to resorption of the 
implant material and bone formation at the interface [1]. The reason behind the 
development of composite by smart combination of biodegradable polymers and bioactive 
ceramics or glasses for tissue engineering have been discusses extensively [2][3]. Briefly: 
they include : a) the possibilities of developing materials with improved mechanical 
properties due to the inherent higher stiffness and strength of the inorganic material, c) the 
possibility of altering the surface topography of the material by combination of nano-sized 
inorganic particles as fillers or coating [4]. As widely reported in literature synthetic 
hydroxyapatite [HAP, Ca10(PO4)6(OH)2] has assumed substantial interest and importance 
because of its chemical similarity to the natural Ca phosphate mineral present in biological 
hard tissue [5][6]. Its surface is highly bioactive and can bond strongly with the host bony 
tissue [7]. The extent of osteointegration between bone and a newly implanted material is 
influenced by many factors including a number of host biological and surrounding tissue 
responses. Properties of the biomaterial surface (such as topography and chemistry) control 
the type and magnitude of cellular and molecular events at the tissue-implant interface [8]. 
The ultimate tissue response to the implanted material may depend on the adsorbed 
proteins that control cell migration and adhesion. Surface properties modulate the 
characteristics of the protein layer adhered [9][10] and such proteins are in the nanometer 
scale [11]. Design of biomaterials with surface properties similar to physiological bone 
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(characterized by surface grain sizes in the nanometer regime ) would undoubtedly aid in 
the formation of new bone at the tissue/biomaterial interface and, therefore, improve 
orthopaedic implant efficacy [12]. With the advent of nanostructured materials (materials 
with grain sizes less than 100 nm in at least one direction [13]) it may now be possible to 
synthesize materials which simulate the surface properties of physiological bone. 
Orthopedic research has placed considerable emphasis on developing bioactive composites 
of nano-scale HA (n-HA) and polymers, [14][15] because bone is composed of apatite and 
collagen on the nano-scale level. Well-dispersed n-HA with an ultrafine structure has the 
potential for improved performance, because its surfaces have minimal defects and it has a 
high ratio of surface area to volume [16][17]. Recently, various nano-hydroxyapatite 
(nHA)/polymer composites scaffolds were developed as potential support for bone 
substitutes due to their compositional analogy to bone [18][19].  
These scaffolds should have a well interconnected porous structure to encourage cell 
proliferation when implanted in the body [20][21]. The manufacture of scaffolds using 
computer-controlled design has received special attention focused on modified rapid 
prototyping methods such as fused deposition modelling, selective laser sintering, 3D 
printing, multiphase jet solidification, and 3D plotting [22][23]. Of the rapid prototyping 
techniques, stereolithography is the most versatile method with the highest accuracy and 
precision [24]. The working principle of stereolithography is based on spatially controlled 
solidification of a liquid photo-polymerisable resin. Using a computer- controlled laser 
beam or digital light projection, and a computer-driven support platform, a 3D object can 
be constructed in a layer-by-layer way [25]. The availability of suitable resin is very 
limited, which in general leads to non-degradable polymer networks. Recently we have 
reported the use of stereolithography  and methacrylate end-functionalised poly(D,L-
lactide) (PDLLA) oligomers with non reactive diluent that allows the fabrication of tissue 
engineering scaffold by computer aided design(CAD) [26]. In this work a combination of 
nano-HA powder and PDLLA/N-methyl pyrollidone resin is proposed as the basis to 
realize composite bioactive scaffold by stereolithography.  
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6.2 Materials and Methods 
6.2.1 Materials 
D,L-Lactide was obtained fromPurac Biochem, The Netherlands. Hexanediol, stannous 
octoate, methacrylic anhydride (MAAH), tocopherol, dibenzopyrazine were purchased 
from Sigma–Aldrich, USA and used without further purification. Triethyl amine (TEA) 
(Fluka, Switzerland), ethyl lactate (Merck, Germany), and technical grade isopropanol and 
acetone (Biosolve, The Netherlands) were used as received. Orasol Orange G was gift 
from Ciba Specialty Chemicals, Switzerland. Lucirin TPO-L (ethyl-2,4,6-
trimethylbenzoylphenylphosphinate) was a gift from BASF, Germany. Analytical grade 
dichloromethane (Biosolve, The Netherlands) was distilled from calcium hydride (Acros 
Organics, Belgium). Nano-sized Hydroxyapatite (particle size < 200nm) was obtained 
from Sigma Aldrich. 
 
6.2.2 Polymer synthesis 
Linear oligomers were synthesised on a 100gr scale by ring opening polymerization of 
D,L-lactide for 40h at 130°C under an argon atmosphere, using stannous octoate as a 
catalyst. Hexanediol were used as initiator to prepare 2-armed oligomers, the molecular 
weights and arm length were varied adjusting the monomer to initiator ratio. Proton-
nuclear magnetic resonance spectroscopy (H-NMR, CDCl3 Varian 300 Mhz) was used to 
determine lactide conversion and oligomer molecular weight. Oligomers were 
functionalised by reacting the terminal hydroxyl groups with methacrylic anhydride in dry 
dicloromethane under an argon atmosphere. The formed methacrylic acid was scavenged  
with triethyl amine (TEA). An excess of 20 mol% of MAAH and TEA per hydroxyl group 
was used. The macromer solution were filtered and precipitated into cold isopropanol. The 
isolated macromers were then washed with water and freeze-dried. The yeld was around 80 
to 85%. 
 
6.2.3 Nano-sized hydroxyapatite 
Hydroxylapatite (HA) and is a calcium phosphate biomaterials with an excellent 
biocompatibility and bioactivity [27] which is probably due to their similarity with the hard 
tissues of the body. As is known, calcium phosphate materials form the main mineral part 
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of calcified tissues, the apatite crystals in bone are formed as thin needles, out 5-20 nm by 
60 nm with a poor crystallinity in the collagen fibre matrix [28]. A nano-hydroxyapatite 
(particle size <200nm) purchase from Sigma-Aldrich was adopted to realize the composite 
resin. 
 
Fig. 6.1: SEM images of nano-sized Hydroxyapatite purchased from Sigma Aldrich 
 
6.2.4 Composite resin formulation and network preparation 
Nano-HAP powder was dispersed in different amount 5%-10%-20% at 60ºC in poly(D,L-
Lactide) dimethacrylate macromere(molecular weight 3.0 kDa). To formulate liquid 
polymerisable poly(D,L-lactide)/n-HAP composite resin, macromer were diluited with N-
methyl-2-pyrollidone.  A viscosity of approximately 5 Pa s will be appropriate for our 
purposes. The resins viscosity was determinated over a range of diluent concentration at 
25°C using a Brookfield DV-E rotating spindle viscometer, equipped with a small sample 
adapter. The shear rate was varied between 0.6 to 5.0 r.p.m.   
Then a solution of of Lucirin TPO-L as biocompatible UV photo initiatior, Tocopherol as 
antioxidant to prevent premature crosslinking of the resins and Orasol Orange G dye in N-
Methyl-2-pyrollidone (NMP) was mixed in. The final resin composition was 68% 
macromer, 31% NMP, 2,7 % Lucirin photo initiator, 0,13% Tocopherol, 0,1% Orange 
Orasol dye. Starting with this resin 4 different types of composite resins have been 
prepared as shown in the table below. 
  
PDLLA 
(wt%) 
NMP 
(wt%) 
Lucirin 
(wt%) 
Tocopherol 
(wt%) 
Orange orasol 
(wt%) 
n-HA 
(wt%) 
0% n-HAP 67 30 2,7 0,13 0,1 0 
5% n-HAP 67 30 2,7 0,13 0,1 5 
10% n-HAP 64,7 32,4 2,7 0,13 0,1 10 
20% n-HAP 64,7 32,4 2,7 0,13 0,1 20 
Tab. 6.1: The different composite resins compositionsrelated to the amount of n-HA added. 
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To obtain network , the resin were irradiated with 365nm UV-light for 20 min (ultralum 
crosslinking cabinet, intensity 3-4 mW/cm2). Silicone rubber moulds, covered with 
fluorinated ethylene-propylene (FEP) film to avoid oxygen inhibition, were employed to 
prepare composite specimen.  
 
6.2.5 Network characterization 
After the UV curing process, PDLLA network were extracted with 3:1 mixtures of 
isopropanol and acetone, and dried at 90°C under nitrogen flow for 2d. The mechanical 
properties of the extracted and dried networks were determinated in tensile and 3-point 
bending tests using a Zwick Z020 universal tensile tester. For the tensile test dumbbell-
shaped specimen were used according with the ISO 37-2 norm. Specimens have been cut 
from a film measuring 70 x 24 x 0.5 mm3 and their dimensions are in accordance with the 
table below: 
 
Dimensions Specimen (mm) 
A Overall length 75 
B Width of ends 12,5 ± 1,0 
C Length of narrow portion 25,0 ± 1,0 
D Width of narrow portion 4,0 ± 0,1 
E Transition radius outside 8,0 ± 0,5 
F Transition radius inside 12,5 ± 1,0 
Tab. 6.2: Measure of dumble-shaped specimen for thensile test according with the ISO 37-2
For the tensile test a cross-head speed of 5.00 mm/min have been used with a load-cell 
of 500N. The elastic modulus was defined as the initial linear modulus and at least five 
specimens were tested for each sample. 
Flexural properties have been evaluated with 3-poin bending test in agreement with the 
ISO 178. Test specimens have been cut in rectangular shape with the following 
dimensions: 
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Dimension Specimen (mm) 
Tickness 0.5±0.01 
Length 40±0.01 
Width 25±0.01 
Support span 174±0.01 
Tab. 6.3: measure of rectangular bars for 3-point bending test according with the ISO178 
 
The cross-head speed have been calculated with the following equation: 
d
ZLR
6
2
=  
where : 
R = Rate of crosshead motion, mm/min 
L = support span, mm 
d = depth of specimen, mm 
Z = rate of straining of the outer fiber, mm/mm/min. it was equal to 0.01 in 
accordance with the ISO 
The equation gave us a cross-head speed of 1 mm/min. 
 
6.2.6 Stereolithography 
The composition of the resins used for stereolithography is summarized in tab.5. 
Depending on the amount of n-HA  used (0,5,10,20%) the weight % of NMP used 
varies  between 45 to 50%. All the 4 types of composite resin contain 2,7% of ethyl-
2,4,6-trimethylbenzoylphenylphosphinate (Lucirin TPO-L photo initiator from BASF), 
0,1% of Orange Orasol G dye (Ciba SC) and 0,13% of α-tocopherol inhibitor (Fluka). A 
commercial stereolithography apparatus (Envisiontec Perfactory Mini Multilens SLA) 
was employed to build designed structures. The building process involves subsequent 
projections of 1280x1024 pixels, each 32x32µm2 in size. Layer with thickness of 25µm 
were cured by irradiating for 25-30s (depending from the resin) with blue light 
(intensity 17 mW/cm2). Composite resin were sonicated for 20 min before using in 
stereolithography to make it more homogeneus and to avoid that nano-HA particles 
could settling on the bottom of the bottle. Uncured excess resin was washed out and the 
diluent, non-reacted macromer and photo-initiator were extracted from the structures 
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with a mixture isopropanol/acetone 3/1. The extracted structure were then dried at 90°C 
for 2d under a nitrogen flow. 
 
6.2.7 Design of porous structures 
The three dimensional design that was chosen for the scaffold architecture was a Double 
Gyroid. The function is triply periodic and is uniquely defined by its unit cell. The 
following trigonometric functions were used: 
15.1))sin()cos()sin()cos()sin()(cos( −⋅+⋅+⋅ xzzyyxabs  
with boundary conditions: 
( ) ( ) pipi 55 222 ≤≤+ zyx &  
K3DSurf v0.6.2 software (http://k3dsurf.sourceforge.net) was used to generate CAD-
files that describes the surfaces of Double Gyroid structure. To obtain porosity of 
approximately 78%, offset value of 1.15 is required. With this architecture cylindrical 
Double Gyroid composite structure have been built using resins with different amount 
of n-HA. Rhinoceros software was used to scale the CAD-files of the structure to the 
desire dimension. Cylinder have been scaled up compared to the desired dimension of 
10x10x10mm3 anticipating the shrinkage upon extraction of non-reactive diluent from 
the built structures.  
 
6.2.8 Morphological analysis 
Structures have been analyzed from a structural point of view using a micro-computed 
tomography (µCT), (Skyscan 1072 at 10µm resolution). Scanning was done at an X-ray 
tube voltage of 52 kV, a current of 179 µA and a rotation angle of 180 °C. After 
reconstruction using the Skyscan software thresholded isosurfaces images were 
obtained. The software was also used to generate pore size distribution maps of the 
structures. To compare the built structures with the software design, the latter were 
evaluated in the same manner as well.  
 
6.2.9 Mechanical test  
Static and dynamic mechanical characterization was performed on poly(D,L-lactyde) 
Double Gyroid structures. Concerning the static compression analysis, test have been 
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performed by using a dynamometric machine (Instron 5566) equipped with a load cell 
of 1 kN and requiring a crosshead spead of 1mm/min. Porous cylindrical specimen 
characterized by height of 10mm and a diameter of 10mm have been tested. At least 
five samples of each composition were measured and the result averaged.  Young’s 
modulus (MPa) was calculated from the stress-strain curve as the slope of the initial 
linear portion of the curve. The evaluation of static curve is preparatory to the dynamic 
mechanical analyses. Indeed, the definition of the elastic range allowed to establish the  
average load and amplitude to apply for the cyclic stimulation. 
Dynamic mechanical analysis were performed by Bose Electroforce biodynamic system 
by superimposing a sinusoidal stress to the specimen and recording the relates strain.  
 
Fig. 6.2: Schematic view of a Dyanmic mechanical analysis in which superimposing a sinusoidal 
stress it was recorded the related strain 
 
Specimens were tested under the stress control mode, where a pre-load of 0.5 N was  
initially applied followed by a dynamic load of 20N. The evolution of elastic moduli 
was evaluated varying the frequency from 0.1 to 9 Hz.  
 
6.2.10 hMSCs culturing and scaffolds seeding 
Bone marrow-derived hMSCs (Clonetic, Italy) were expanded and cultured in 
proliferation medium consisting of α-modified Eagle’s medium (α-MEM)(Biowittaker, 
Belgium), 10% foetal bovine serum (FBS), 100U/ml penicillin and 0,1 mg/ml 
streptomycin (Hyclone, UK). Medium was refreshed three time per week and cells were 
trypsinised whenever a confluency of 70-80% was reached. in a humidified atmosphere 
containing 5% CO2 at 37°C.  Prior to seeding, the scaffolds were disinfected in 70% 
ethanol (1h) and then 1% antibiotic/antimycotic in phosphate-buffered saline (PBS) 
(2h), and incubated in medium (2h) to allow pre-wetting of the material and protein 
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adsorption on its surface. hMSCs were trypsinised and resuspended in 50?l of medium 
at a concentration of 4 x 105 cells per scaffold seeding volume. The cell suspension was 
pipetted on top of the scaffolds that were placed each in a well of non cell-adherent 
polystyrene surface and incubated  for 2 h in a humidified atmosphere (37°C, 5% CO2). 
Scaffold were maintained in culture for 28 days, with the cell culture medium being 
changed every 3-4 days.  
  
6.2.11 Alkaline phosphatise (ALP) assay 
The cell-scaffold constructs were removed from the culture plates on days 1, 7, 14, 21 
and 28 and washed with PBS (Sigma–Aldrich, Italy). The cells were lysed in Cell Lysis 
Buffer (BD Pharmingen ™) and ALP activity was measured using a SensoLyte™ pNPP 
alkaline phosphatase assay kit (AnaSpec, DBA, Milano) according to the 
manufacturer’s instructions. The ALP activity was read off a standard curve obtained 
with ALP concentrations of 0 - 200 ng/ml (detection limit 0.01 ng/ml). Double stranded 
DNA (dsDNA), as a marker for cell number, was measured using a PicoGreen® dsDNA 
quantification kit (Molecular Probes). First, 100 ?l of 200x diluted Picogreen® dsDNA 
quantification reagent was added to 100 ?l of cell lysate in a flat-bottomed, 96-well 
plate. Following 10 min incubation, the fluorescence of Picogreen® was determined at a 
wavelength of 520 nm after excitation at 585 nm using a plate reader (multilabel counter 
1420 Victor, Perkin-Elmer, Italy). dsDNA was quantified according to a calibration 
curve of l-dsDNA standard in 10 mM Tris, 1 mM EDTA, pH 7.5, buffer. Each 
experiment was performed three times in triplicate. 
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6.3 Results and Discussions 
6.3.1 Macromers synthesis 
The monomer conversion and the arm length of the synthesised lactide oligomers could 
be derived from 1H-NMR spectra. A typical spectrum is depicted in Figure. The degree 
of functionalization of the obtained oligomers was determined from the peak areas 
corresponding to  the methacrylate protons (5,65 and 6.2 ppm) and the hexandiol -
CH2O- protons (4.1 ppm). Conversion reached was above 98%.  
Macromers were diluited with varying amounts of N-methyl-2-pyrollidone (NMP), and 
nano-HA was added in different wt%. the viscosity of the composite resin was 
determined at 25°C over a range of shear rates. Behaviour of the resin was essentially 
Newtonian and it clearly changes with the amount of n-HA.  so we modified the 
composition of the resin, in particular the amount of solvent, depending on the amount 
of Hydroxyapatite 
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Fig. 6.3: The resin viscosity of PDLLA/nano-HA resin as a function of the amount of nano-HA. 
η (centipoises) η (Pa s) 
45% of NMP 50% of NMP 45%of NMP 50% of NMP 
0% n-HA 4220,38 6357,14 4,22 6,36 
5% n-HA 4530,41 7885,71 4,53 7,89 
10% n-HA 5042,86 10371,43 5,04 10,37 
20% n-HA 6954,29 14610,00 6,95 14,61 
Tab. 6.4: Viscosity of the composite resin related to the amount of solvent and n-HA used during 
the preparation. 
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6.3.2 Network characterization 
The mechanical properties of the extracted and dried composite networks were 
determined in tensile and 3-point bending test.; the result are shown in Figure and table. 
Results are shown in the graph below and it’s possible to see that the elastic modulus 
rise with the amount of n-HA. 
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Fig. 6.5: the flexural modulus (E’) as function 
of nano-HA amount. 
 
 
 
Tab.5: Tensile properties of photo 
crosslinked PDLLA/nano-HA networks. 
Determination of the Young modulus (E’), 
tensile strength (σmx) and strain at failure 
(εmax)
 
The 3-point bending test follow the trend of tensile as it’s possible to see in the graph 
below: 
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Fig.5: the flexural modulus (E’) as function 
of nano-HA amount  
 
 
Tab.6: The flexural properties of photo 
crosslinked  PDLLA composite network. 
The presence of the HA nanocrystals substantially increase the tensile modulus relative 
to the PDLLA polymer. For the nanocomposite containing 20% n- HA, the modulus 
calculated from the 3-point bending test even reaches to 5.13 GPa as compared to 
3.06Gpa for pure PDLLA. For the tensile test  the increase in mechanical properties is 
n-HAP 
(%) 
σmax 
(MPa) 
E 
(Gpa) 
εmax 
(%) 
0% 20.84±3.72 1.70±0.17 1.33±0.2 
5% 19.44±2.15 1.88±0.12 1.10±0.2 
10% 25.88±3.33 2.06±0.06 1.46±0.3 
20% 27,80±3,20 2.13±0,13 1,41±0,2 
n-HAP 
(%) 
σmax 
(Mpa) 
E 
(Gpa) 
εmax 
(%) 
0% 65.98±9.51 3.06±0.43 3.5±1.3 
5% 45.33±9.44 4.05±0.33 1.3±0.2 
10% 38.33±6.44 2.79±0.32 1.7±0.6 
20% 50.62±6.48 5.13±0.61 1.2±0.2 
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not so evident as for the 3-point bending test, this is probably due to the fact that, as we 
will see in the SEM images, n-HA mainly tend to localize on the surface of the material 
after the cross-linking process. 
 
6.3.3 Stereolithography 
Stereolithography is a solid freeform technique (SFF) that was introduced in the late 
1980s. Although many other techniques have been developed since then, 
stereolithography remains one of the most powerful and versatile of all SFF techniques 
[29]. Complex structures can be built by illuminating sequential layers of a 
polymerisable resin using digital pixel mask or arrays or mirrors. In stereolithography, 
control of the thickness of the layer that is cured is essential. For a given resin, the cure 
depth is determined by the energy of the light to which the resin is exposed. This energy 
can be controlled by adjusting the power of the light source, and the scanning speed (for 
laser systems) or the exposure time (for projection systems). Time of exposure depend 
from the resin and was calculated from the Working curve, as shown in fig. the 
experimental measurements of working curve are obtained by measuring the curing 
depth under various UV exposure times. To create polymer-ceramic composite objects 
[30][31], ceramic particles (e.g. allumina or hydroxyapatite) are homogeneously 
suspended in the stereolithography resin and photo-polymerised in the SLA. Processing 
of the resin is more difficult, as the viscosity of the resin can significantly increase upon 
addition of the powder. Maximum ceramic contents of up to 53 wt% have been 
reported. The curing characterization of composite resins with different amount of n-HA 
(0,5,10,20%) has been compared. The result indicates that for high exposure time the 
curing depth is in inverse proportion with the amount of n-HA, in particular resin with 
20% of n-HA showed a plateau over 90µm for the Dp (light penetration depth). 
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Fig. 6.6: Stereolithography working curves of PDLLA/nano-HA composite resin containing 
different amount of nano-HA 
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With this dye containing resin, stereolithography was used to build ISO37-2 non-porous 
dumbbell-shaped for tensile testing, ISO 178 non porous specimen for tensile test and 
porous Double Gyroid structure. 
 
6.3.4 Analyses of porous structures 
Porosity and pore size have significant ramifications on the ability of tissue engineering 
scaffolds to support bone regeneration for several reasons. First, porosity and pore size 
have been shown to affect cell attachment efficiency, which consequently impacts the 
cell seeding density, cell distribution, and cell migration [32][33]. These factors have 
been shown to affect osteogenic differentiation through changes in signalling distances 
[34]. Moreover, pore size and porosity have a significant effect on the mechanical 
strength of a scaffold. Sufficient scaffold strength to provide mechanical support to a 
defect is often required for a hard tissue engineering scaffold such as bone, especially 
when the bone is load bearing [35]. Further, porosity and pore size affect the ability of 
the scaffold to promote in vivo osteoconduction and vascularization. Integration of 
native tissue into a scaffold is fostered through growth into interconnected pores, and 
thus both optimal and minimal pore sizes have been established to support tissue 
ingrowth [36]. Finally, pore size and porosity affect in vivo and in vitro cell signaling, 
which in turn affects osteoblastic differentiation of MSCs and the production of ECM 
protein. The  double gyroid architecture has an open accessible pore network where the 
number, size and location of the interconnections play an important role in cell seeding, 
and in nutrient transport and cell migration during cell culturing phase.  
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Fig. 6.7: Visualization of the Double gyroid porous architecture. Columns : (1) CAD-Design of the 
Double gyroid structure, (2) µCT scanning of the built structure 
 
The presence of n-HA doesn’t affect the porosity and the interconnectivity of the 
structure, their value and specific surface area remain the same for the composite 
structure. Table 8 shows the parameters related to the pore network architecture of 
PDLLA and PDLLA/n-HA composite scaffold. 
 
 Porosity 
(vol%) 
Specific surface area 
(mm-1) 
Average pore size 
(mm) 
Double gyroid HAP 77,46±0,69 13,21±0,72 0,695±0,015 
Double gyroid 78,16±1,54 13,89±0,68 0,745±0,020 
Tab. 6.7:  comparison between structural parameters for Double Gyroid architecture obtain with 
PDLLA and PDLLA/nano-HA composite resin. 
 
Scanning electron microscopy (SEM)(Philips XL30 operated at 10 (kV) was used to 
assess the porous architecture and the distribution of the n-HA within the structure.  
Figure 7 shows 3 different scaffold architecture: (A) Scwartz, (B) Diamond and (C) 
Double Gyroid built with PDLLA  resin with 5% of n-HA. Geometry of the structures 
remain almost unaffected by the presence of the n-HA and is still possible to notice the 
layer by layer architectures that characterized the stereolitography  process.  
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Fig. 6.8: SEM images of porous PDLLA/nano-HA composite structure with different architecture 
built by stereolithography: (A) Diamond architecture, (B) Schwartz architecture, (C) Double 
Gyroid architecture. 
 
Figure 8 shows the comparison between structures with different amount of n-HAP 
(0%, 5%, 10%, 20%)  and it is possible to notice how the n-HAP is well dispersed 
inside the scaffold. It was expected to find the n-HAP inside the trabecule of the 
structure but the sem reveal that  the n-HA is mainly localized on the surface of the 
scaffold. This is probably due to a phase separation between the hydrophobic PDLLA 
and the hydrophilic n–HAP, during the cross-linking process. 
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Fig. 6.9: comparison between Double gyroid structures with different amount of n-HA, respectively 
0%, 5%, 10% 20%. 
 
  Using high resolution SEM is possible to find small cluster of n-HA inside the matrix 
of PDLLA. This clusters could affect in a bad way the mechanical properties of the 
structure reducing its mechanical strength. 
 
Fig. 6.10: High resolution SEM of composite structure. It evaluates the presence of n-HA cluster 
inside the PLLA matrix. 
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6.3.5 Mechanical characterization  
The influence of the nano-HAP on the mechanical properties of the structures was 
analysed as well through static and dynamic compression test.. The Young’s modulus 
varies from 13 MPa for PDLLA Double Gyroid structures till over 30 MPa for the 
Composite PDLLA/nano-HAP structures with 20% amount of hydroxyapatite. The plot 
shows the two stress-strain curves for PDLLA (red plot) and PDLLA/n-HAP 20 wt% 
(blue plot) in . The curve describes the mechanical behaviour of porous systems under 
static compression test: it shows a linear elasticity till failure describing a typical brittle 
behaviour. 
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Fig. 6.11: Stress-Strain diagram of PDLLA and PDLLA/n-HA  composite structures at similar 
porosity. 
  
n-HAP 
(%) 
σmax 
(Mpa) 
E 
(Gpa) 
εmax 
(%) 
0% 0.61±0.20 12.27±2.6 0.07±0.01 
10% 0.68±0.20 23.14±4.9 0.07±0.02 
20% 1.23±0.20 30.76±6.9 0.09±0.01 
Tab. 6.8: Mechanical properties of Double Gyroid structures as function of  the amount of n-HA. 
 
Observing the plot it is possible to see some discontinuity point due to the particular 
architecture of the scaffold. Double Gyroid is characterized by two interpenetrating non 
communicating Gyroid structure so the discontinuity point could be  due to the collapse 
of one of the Gyroid structure before the other. Dynamic mechanical analysis (DMA) 
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measure the response of a material to a sinusoidal stress over a range of frequencies and 
is sensitive to chemical and physical structure of polymers and their composites.[37] 
DMA was carried out on cylindrical specimen (measuring 10x10mm) characterized by 
Double Gyroid architecture. See supporting information for details on the calculation of 
the various dynamic properties. The main variables obtained from DMA are the storage 
modulus (E’),which represent the elastic component of a system and is equivalent to the 
energy stored through deformation, the loss modulus (E’’) which represents the viscous 
component and is equivalent to the energy dissipated through deformation, and tan(δ), 
which is the ratio E’/E’’ and provides a measurement of the damping of the material. 
Specimens were tested over a range of frequency (from 0.1 to 9 hz), this enabled to 
estimate a comparative analysis of the storage modulus “E’” (elastic component) 
equivalent to the energy stored through deformation and the loss modulus “E’’” 
equivalent to the energy dissipated through the cycled stimulation.  
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Fig. 6.12: the principal dynamic properties are : (a) the storage or elastic modulus (E’), that is a 
measure of how elastic the material is and ideally is equivalent to the Young’s modulus. (b) the loss 
modulus (E’’), also called the viscous or imaginary modulus that represent the energy lost to 
friction and internal motion. 
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Moreover the test highlights the viscoelastic behaviour of the samples showing that E’ 
increases with frequency. Otherwise loss modulus E’’ is not significantly affected as 
frequency varies.   
 
6.3.6 ALP and DNA assays. 
In order to evaluate the biocompatibility and osteogenic properties of the PDLLA/nano-
HAP composite scaffold hMSCs were seeded and cultivated for 21 days in basic 
medium. The proliferation of hMSCs in direct contact with the scaffold was 
quantitatively measured by DNA Picogreen assay. According to our results the nano-
HAP had a positive effect on cell adhesion and proliferation. The presence of nano-HAP 
is a bioactive signal for cells and it encourages proliferation on the structure. In fact the 
proliferation peak is reached at 14 days for the PDLLA/nano HAP composite scaffold 
with 10 wt% of HAP. Meanwhile samples with 20 wt% of nano-HAP have a different 
behaviour and at 21 days proliferation is still growing  probably due to the greater 
presence of HAP on the surface that generates a tortuous walk for the cells. It follows 
that cells have great difficult to see each other and reach confluence.  
 
 
Fig. 6.13: DNA and ALP assays for composite PDLLA scaffold with different amount of nano-HAP 
 
A preliminary study of the differentiation of hMSCs towards the osteoblastic phenotype 
was quantitatively determined by carrying out a destructive assay for ALP activity using 
the p-nitophenyl phosphate method. ALP is an enzyme produced by differentiating 
osteoblasts and can be responsible for the construction of bone matrix. An increase in 
ALP activity was observed for composite scaffold if compared with the pure PDLLA 
ones. This is a confirmation that nano-HAP have a central role in cell differentiation 
towards the osteoblastic phenotype. Moreover, ALP activity shows a peak at 14 days 
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both for pure PDLLA scaffold than for composite ones. However, the ALP data offer 
only a preliminary indication and further investigation of mineralization should be 
performed in order to evaluate the formation of mineral deposits and gene espressions, 
required to reproduce the bone ECM matrix. 
 
6.4 Conclusions  
Scaffolds for osteogenesis should mimic bone morphology, structure and function to 
optimize integration into surrounding tissue. It is well-known that bone is a structure 
composed of hydroxyapatite (Ca10(PO4)6(OH)2) crystals deposited within an organic 
matrix (95% is type I collagen) [38]. Nanometric-scale Hydroxyapatite seems more 
similar to bone apatite, and it has the ability to promote the attachment of cultured 
osteoblasts and to improve their metabolic activity. The major objective of this study 
was to create biocompatible and bioactive PDLLA/nano-HAP composite scaffolds for 
bone tissue engineering. Many studies have suggested methods for fabricating 3D 
scaffolds. However, the limitation of conventional methods is that they cannot perfectly 
control the pore structure. This means that cells and/or tissues cannot easily penetrate 
into the scaffold. The saturated cell density on the scaffold surface eventually prohibits 
cell and/or tissue proliferation, regeneration, and other biological activities in the long 
run. To overcome these problems, new techniques are required. For this, we suggested 
the stereolithography for easily creating 3D scaffolds with controlled macropores using 
composite materials. This produces scaffolds whose properties are controlled and 
reproducible. The scaffold used for bone regeneration must be biocompatible and 
bioactive. Given that bone is a typical example of a nano-composite, n-HAP could have 
an important role in various areas of bone tissue engineering, including the formation 
and maintenance of the tissue-biomaterial interface. This has focused recent attention on 
n-HAP as a bone tissue engineering material. PDLLA/nano-HAP scaffolds with well 
interconnected pores and good reproducibility were successfully fabricated using 
stereolithography technique, and the biological properties of the biocomposites were 
investigated for the first time. The stereolithography resin was a homogeneous 
dispersion that showed no settling of nano-HAP particles. Different  composite structure 
were prepared from this resin by stereolithography (Diamond, Schwartz, Double 
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Gyroid). SEM images show that the ceramic particles are exposed to the surface, 
allowing interaction of cells with the nano-HAP. Mechanical tests indicated that the 
composite scaffold had higher compressive modulus than the PDLLA one. In addition, 
the ALP activity of hMSCs in direct contact with PDLLA/nano-HAP scaffolds  were 
significantly higher than the pure PDLLA after 14 days of culture, indicating that the 
nano-HAP improved biological properties of the materials.  
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APPENDIX 1 
 
Dynamical mechanical analysis 
DMA can be simply described as applying an oscillating force to a sample and 
analyzing the material’s response to that force (Figure A.1). From this, one calculates 
properties like the tendency to flow (called viscosity) from the phase lag and the 
stiffness (modulus) from the sample recovery[1]. These properties are often described as 
the ability to lose energy as heat (damping) and the ability to recover from deformation 
(elasticity).DMA is a very suitable technique for investigating the viscoelastic 
properties of polymeric materials in a wide range of temperatures and frequencies[2]. 
Furthermore, DMA measures the dynamic response of a particular polymeric system, 
being specially adequate to evaluate the performance of biomaterials when working 
under the cyclic solicitations generated by the human body physiological 
movements[2][3]. 
 
 
Fig. A.1: The DMA supplies an oscillatory force, causing a sinusoidal stress to be applied to the 
sample, which generates a sinusoidal strain[3]. 
 
The applied force is called stress and is denoted by the Greek letter, σ . When subjected 
to a stress, a material will exhibit a deformation or strain, γ . Most of us working with 
materials are used to seeing stress–strain curves as shown in Figure A.2. These data 
have traditionally been obtained from mechanical tensile testing at a fixed temperature.  
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Fig. A.2: Stress–strain curves relate force to deformation [3]. 
 
The slope of the line gives the relationship of stress to strain and is a measure of the 
material’s stiffness, the modulus. The modulus is dependent on the temperature and the 
applied stress. The modulus indicates how well a material will work in specific 
application in the real world. In DMA, a complex modulus(E*), an elastic modulus (E’), 
and an imaginary (loss) modulus (E”) [1] are calculated from the material response to 
the sine wave. These different moduli allow better characterization of the material, 
because we can now examine the ability of the material to return or store energy (E’), to 
its ability to lose energy (E’’), and the ratio of these effects (tan delta), which is called 
damping[4]. 
 
Applying a dynamic stress to a sample 
If we take a sample at constant load and start sinusoidally oscillating the applied stress 
(Figure A.3), the sample will deform sinusoidally. This will be reproducible if we keep 
the material within its linear viscoelastic region. For any one point on the curve, we can 
determine the stress applied as: 
σ = σ0 sin(ωt) 
where σ is the stress at time t, σ0 is the maximum stress, ω is the frequency of 
oscillation, and t is the time. The resulting strain wave shape will depend on how much 
viscous behavior the sample has as well as how much elastic behavior. We can look at 
the two extremes of the materials behavior, elastic and viscous, to give us the limiting 
extremes that will sum to give us the strain wave. Let’s start by considering the material 
at the Hookean region. The strain at any time can be written as: 
)sin()( 0 tEt ωσε =  
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where ε(t) is the strain at anytime t, E is the modulus, σ0 is the maximum stress at the 
peak of the sine wave, and ω is the frequency. Since in the linear region σ and ε are 
linearly related by E, we can also write that: 
)sin()( 0 tt ωεε =  
where ε0 is the strain at maximum stress. 
 
Fig. A.3: When a sample is subjected to a sinusoidal oscillating 
stress, it responses in a similar strain wave provided the material stays within its elastic limits[3]. 
 
The viscous limit was expressed as the stress being proportional to the strain rate, which 
is the first derivative of the strain. 
)cos()( 0 tdt
d
t ωηωσσηε ==  
)2/sin()( 0 piωηωσε += tt  
)2/sin()cos()( 00 piωωεωωεε +== ttt  
where η is the viscosity. This behaviour is shown in Figure A.5,  
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Fig. A.4: out of phase response of a viscous material 
 
Now let’s take the behaviour of the material that lies between these two limits. 
)sin()( 0 δωεε += tt  
The difference between the applied stress and the resultant strain is an angle, δ, that 
varies in a range between 0°(elastic material) and 90°(viscous material). This behaviour 
is shown in figure A.4 (c).  
 
Figure A.5:viscoelastic material falls in between the elastic and viscous material 
Last formula can be rewritten in this way using trigonometry: 
δωδϖεε sin)cos(cos)[sin()( 0 ttt += ] 
We can now break this equation into the in-phase  and out-phase strains that 
corresponds to curves like those in figure A.3 and A.4, respectively. 
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)sin(0' δεε =  
)cos(0'' δεε =  
And the sum of these two component gives the complex strain on the sample 
'''* εεε i+=  
Basically this approach allows us to divide a single modulus into two terms, one related 
to the storage energy and another related to the loss energy.  
 
Calculating dynamic properties 
A material subject to a sinusoidal stress is characterized by a certain value of strain at 
the peak of the sine wave and an angle defining the lag between the stress sine and the 
strain sine wave[4]. We can first calculate the storage or elastic modulus, E’. This value 
is a measure of how elastic the material is and ideally is equivalent to Young’s modulus. 
E’ is calculated as follows [3]: 
δδεσ cos)/(cos)/(' 000 bkfE ==  
Where δ is the phase angle, b is the sample geometry terms, f0 is the force applied at the 
peak of the sine wave, and k is the sample displacement at peak. 
The loss modulus E”, also called the viscous or imaginary modulus is calculated from 
the phase lag between the two sine waves as: 
δδεσ sin)/(sin)/(" 000 bkfE ==  
The tangent of the phase angle is one of the most basic properties measured. Some 
earlier instruments only recorded phase angle, and consequently the early literature uses 
the tan d as the measure for many properties. This property is also called the damping, 
and is an indicator of how efficiently the material loses energy to molecular 
rearrangements and internal friction. It is also the ratio of the loss to the storage 
modulus and therefore is independent of geometry effects. It is defined as: 
'" /'/")tan( εεδ == EE  
Because it is independent of geometry, tan(δ) can be used as a check on the possibility 
of measurement errors in a test. For example, if the sample size is changed and the 
forces are not adjusted to keep the stresses the same, the E’ and E” will be different but 
the tan(δ) will be unchanged. A change in modulus with no change in the tan(δ) should 
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lead one to check the applied stresses to see if they are different. Once we have 
calculated the basic properties all the other properties are calculated from them [5].  
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APPENDIX 2 
Poly(D,L-lactide) oligomers synthesis. 
Poly(D,L-lactide) (PDLLA) is a rigid, amorphous biodegradable polyester typically 
made by ring-opening polymerization of its cyclic diester dimer, lactide [1]. 
 
 
Fig. A.1: Ring-opening polymerization reaction of D,L-Lactide 
 
A large variety of organometallic compounds have been studied as possible catalysts for 
the synthesis of polylactide. Tin(II)bis-2-ethylhexanoic acid (stannous octoate or 
SnOct2) is a frequently used because it leads to high yields, high molecular weights and 
it is FDA (food and drug administration) approved [2]. 
 
 
Fig. A.2: Tin(II)bis-2-ethylhexanoic acid (stannous octoate or SnOct2) is one of the mostly 
frequently used catalyst in ring-opening polymerization 
 
Often an alcohol is used as a co-initiator and the initiator/co-initiator complex is then 
the true initiator of the polymerization process . Mono and bi-functional alcohols yield 
linear polymers, while co-initiators with more than two alcohol groups give star-shaped 
polymers. 
 
Fig. A.3 : Co-initiators with different functionalities 
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The ring opening polymerization is thought to follow the coordination-insertion 
mechanism [2]. The three-step coordination-insertion mechanism for the ROP of cyclic 
esters was first formulated in 1971 by Dittrich and Schulz [3]. The mechanism for the 
Sn(Oct)2-catalyzed ROP has been the subject of much more controversy. Recent 
investigations [4][5] have allowed for the characterization of several intermediate tin 
complexes and strongly support a coordination-insertion mechanism rather than a 
cationic or activated-monomer mechanism [6]. Penczek and co-workers suggest that 
when SnOct2 is mixed with an alcohol an initiating complex is formed prior to 
polymerization The tin alkoxide complex thus formed then initiates the polymerization 
(Fig.4). 
 
Fig. A.4: Tin Alkoxide Complex Initiated Polymerization of  Lactones 
 
The methyl group on the alpha carbon of polylactide causes chirality at this carbon, and 
thus D, L and DL isomers are possible. Poly-L-lactide (PLLA) is made from L-lactide 
and poly-D-lactide (PDLA) is made from D-lactide, while poly-D,L-lactide (PDLLA) is 
made from DL-lactide which is a racemic mixture of the D and L isomers. The meso 
form has both the D and L configuration on the same dimer molecule (Fig.5). 
 
 
Fig. A.5: The three different configuration of lactide. 
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PDLLA ia a completely amorphous polymer characterized by a glass transition 
temperature of approximately 55°C, and an elasticity modulus close to 3 GPa . It is one 
of the few biodegradable polymers with mechanical properties that approach those of 
the bone [1]. Because of its lack of crystallinity, PDLLA has a much lower tensile 
strength and modulus of elasticity than PLLA. The lack of crystallinity also causes 
PDLLA to degrade faster than PLLA. To make oligomers suitable for photo-initiated 
crosslinking, they have to be functionalized with crosslinkable entities; most often 
carbon-carbon double bonds. PDLLA networks can be formed by (photo-initiated) 
radical polymerization of polylactide oligomers end-functionalised with an unsaturated 
moiety such as methacrylate [7], acrylate [8] or fumarate [9]. Methacrylate is the end-
group that has been most frequently used to functionalize oligomers. Davis et al.[10] 
have functionalized D,L-lactide and ε-caprolactone based oligomers in this way: 
 
 
Fig. A.6: the reaction of an hydroxyl group with methacryloyl chloride 
 
The percent methacrylation varied from 70 to 100 %. 
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Summary 
Tissue engineering is set to revolutionize the treatment of patients and contribute 
significantly to life sciences in the next millennium. It is based on the concept that cells 
seeded onto 3D bioresorbable scaffolds can recreate native tissues under suitable in 
vitro and in vivo conditions. General requirements involve scaffold morphology in 
terms of pore size and pore inteconnectivity which assure cell growth and the transport 
flow of nutrients and metabolic waste. Moreover the control of surface also enable  a 
suitable  cell attachment and promote cell differentiation and proliferation. Furthermore, 
the biocompatible degradation of the scaffold material has to proceed  appropriately and 
in sync with  the formation of tissue. In this thesis, the implementation and optimization 
of new interesting techniques for the realization of 3-Dimensional scaffolds was 
investigated to develop systems able to elicit favourable tissue response. First part of the 
thesis has been focused on the realization of bioactive composite scaffold obtained with 
different preparation techniques like salt leaching in combination with phase inversion. 
The PCL/HA scaffolds fabricated by the PI/SL (phase inversion/salt leaching) method 
(Chapter 3) showed a bimodal porosity, interconnected macropores (100–200 mm) 
were created by the leaching of the NaCl particles, and smaller, closed pores (10–45 
mm) were created by the controlled solvent removal via non-solvent exchange. This 
method promotes more efficient exposure of HAP at the surface of polymer/bioceramics 
composite scaffold as confirmed by Sem images. Moreover presence of HAP enhances 
mechanical properties with an optimal response under compression in the case of 20% 
of HAP ceramic phase, while morphology and thermal properties seem to be unaffected. 
Cellular response and biological activity of the scaffold were evaluated in vitro by 
culturing the scaffolds with human sinovium-derived MSCs for 2 weeks. It was found 
that PCL scaffold obtained with PI/SL techniques supportes the seeding and 
proliferation of MSCs. In particular the presence of HAP encourages the differentiation 
process through the osteoblast phenotype. However, requrements of porosity, 
biocompatibility and biodegradability are often in conflict with the needful of adequate 
mechanical properties which can match those of the tissues at the site of implantation. 
Noteworthy, the measured compressive moduli of the prepared scaffolds is rather low 
compared to that of human bone. This is due to the highly porous structure of the 
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fabricated scaffolds and the poor mechanical properties of the PCL itself, independently 
upon the HAP reinforcement.  
The definition of composite systems characterized by tailored degradation properties, 
coupled with a controlled decay of mechanical response, may guarantee the 
achievement of the long-term success of a tissue engineered construct. Three 
biodegradable scaffolds based on a PCL and HYAFF11® matrix, with tailored chemical 
and physical properties, were developed by combining a filament winding technique 
with a phase inversion/salt leaching method (Chapter 4). The combined use of SEM 
and computer microtomography (mCT), investigation demonstrated the contribution of 
single composite phases to the basic morphological features. The integration of 
biodegradable PLA fibers into the polymer matrix guarantees a mechanical response 
which is ideal for maintaining the spaces required for cellular in-growth and matrix 
production. Furthermore, the addition of bioactive calcium phosphates particles, 
generates needle-like HAP crystals which interact with the packed fbers into the PCL 
matrix. This interaction dramatically improves the mechanical response in compression, 
up to an order of magnitude. The further presence of an interconnected macroporous 
structure with pore size able to promote cell seeding and proliferation, combined with 
suitable mechanical features, concurs to define a composite scaffold to be used as a 
candidate for bone tissue engineering. A preliminary in vivo test on fibres reinforced 
scaffold in three different configuration,  performed from Orthopaedic Institute Rizzoli 
of Bologna (Italy),  confirm the good biocompatibility and the positive bioactive 
response of substrates to the biological environment. In order to overcome the main 
limit of the salt leaching technique on precisely controlling pore size, pore geometry, 
and spatial distribution of pores the use of stereolithography (Chapter 5) methods has 
been explored to accurately prepare tissue engineering scaffolds with a controlled 
architecture of pores by computer aided modelling. The synthesis of macromers is also 
the main factor to impact the physical properties of the final network. PDLLA 2- armed 
macromers of molecular weight of 3.0 kDa have shown to be processable by 
stereolithography. A non reactive diluent (NMP) is used to decrease resin viscosity 
during the fabrication process, and is extracted from the network afterwards. the choice 
of photo-initiator depends primarly on the used light source and solubility in the resin. 
A concentration of photo-initiator as used here (2-4 wt%) ensure high reactivities during 
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the fabrication process. A dye was shown to be essential for accurate fabrication by 
stereolithography. In this context, the use of 0.2 wt% of orange dye limits the 
penetration depth of the light, so thin layers with a controlled thickness can be cured. 
Porous scaffolds were designed with computer software using the PDLLA-based resin. 
The modelling  by mathematical equations (the Schwartz, the Diamond and the Double 
Gyroid architecture) assures an excellent reproduction of the design, with pore size and 
porosities suitable  for (bone) tissue engineering. In particular Double Gyroid 
architecture showed great values of porosity and high permeability due to great pore 
interconnection. The mechanical properties response in compression shows really good 
elastic modulus and mechanical strength, even if the scaffold shows a typical brittle 
behaviour. Moreover it was shown that the open accessible architecture has improved 
cell seedability in fact hMSCs readily adhere and proliferate on scaffold surface. 
Besides the aforementioned PDLLA, a PDLLA/nano-hydroxyapatite composite resin 
has been synthesised and used in stereolithography (Chapter 6). The stereolithography 
resin was a homogeneous dispersion that showed no settling of nano-HAP particles. The 
fabricated composite structure were shown to have a high hydroxyapatite  content at the 
surface as SEM images reveal and show increasing mechanical properties with the 
amount of nano-HAP used. In addition preliminary biological evaluation with hMSCs 
show higher value of ALP activity for the composite scaffolds if compared with the 
pure PDLLA. In summary, compared with the scaffold produced by the conventional 
method, the PDLLA/nano-HAP composite scaffold fabricated by stereolithography 
exhibited superior mechanical properties and good in vitro bioactivity. These findings 
suggest that they may be suitable for bone implants. In the future, further structure will 
be realized in order to reach the best compromise between mechanical  and 
morphological properties using new mathematical equation. 
We can conclude that different scaffolds obtained by stereolithography technique show 
good and predictable internal architecture with a précis control of pore size, pore 
geometry, spatial distribution of pores and construction of internal chamber, meanwhile 
scaffolds obtained with conventional phase inversion/salt leaching technique is able to 
produce highly porous structure with tailored chemical and physical properties. Finally 
the possibility to use, for the first time, a composite resin of PDLLA and nano-HAP in 
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stereolithography technique opens great challenge in scaffolds design for bone tissue 
engineering.   
